Refine
Year of publication
Document Type
- Doctoral Thesis (25)
- Article (21)
Has Fulltext
- yes (46)
Is part of the Bibliography
- no (46)
Keywords
- - (12)
- Proteomanalyse (9)
- Staphylococcus aureus (6)
- Proteomics (4)
- Infektion (3)
- SNP (3)
- host-pathogen interactions (3)
- proteomics (3)
- CRISPR/Cas9 (2)
- GWAS (2)
Institute
- Interfakultäres Institut für Genetik und Funktionelle Genomforschung (UMG) (46) (remove)
Publisher
- MDPI (8)
- Frontiers Media S.A. (4)
- Wiley (3)
- S. Karger AG (2)
- Elsevier (1)
- Ferrata Storti Foundation (1)
- Taylor & Francis (1)
Sturgeons are among the most ancient linages of actinopterygians. At present, many sturgeon species are critically endangered. Surrogate production could be used as an affordable and a time-efficient method for endangered sturgeons. Our study established a method for identifying and isolating type A spermatogonia from different developmental stages of testes using flow cytometric cell sorting (FCM). Flow cytometric analysis of a whole testicular cell suspension showed several well-distinguished cell populations formed according to different values of light scatter parameters. FCM of these different cell populations was performed directly on glass slides for further immunocytochemistry to identify germ cells. Results showed that the cell population in gate P1 on a flow cytometry plot (with high forward scatter and high side scatter parameter values) contains the highest amount of type A spermatogonia. The sorted cell populations were characterized by expression profiles of 10 germ cell specific genes. The result confirmed that setting up for the P1 gate could precisely sort type A spermatogonia in all tested testicular developmental stages. The P2 gate, which was with lower forward scatter and side scatter values mostly, contained type B spermatogonia at a later maturing stage. Moreover, expressions of plzf, dnd, boule, and kitr were significantly higher in type A spermatogonia than in later developed germ cells. In addition, plzf was firstly found as a reliable marker to identify type A spermatogonia, which filled the gap of identification of spermatogonial stem cells in sterlet. It is expected to increase the efficiency of germ stem cell culture and transplantation with plzf identification. Our study thus first addressed a phenotypic characterization of a pure type A spermatogonia population in sterlet. FCM strategy can improve the production of sturgeons with surrogate broodstock and further the analysis of the cellular and molecular mechanisms of sturgeon germ cell development.
Life-threatening toxic shock syndrome is often caused by the superantigen toxic shock syndrome toxin-1 (TSST-1) produced by Staphylococcus aureus. A well-known risk factor is the lack of neutralizing antibodies. To identify determinants of the anti-TSST-1 antibody response, we examined 976 participants of the German population-based epidemiological Study of Health in Pomerania (SHIP-TREND-0). We measured anti-TSST-1 antibody levels, analyzed the colonization with TSST-1-encoding S. aureus strains, and performed a genome-wide association analysis of genetic risk factors. TSST-1-specific serum IgG levels varied over a range of 4.2 logs and were elevated by a factor of 12.3 upon nasal colonization with TSST-1-encoding S. aureus. Moreover, the anti-TSST-1 antibody levels were strongly associated with HLA class II gene loci. HLA-DRB1*03:01 and HLA-DQB1*02:01 were positively, and HLA-DRB1*01:01 as well as HLA-DQB1*05:01 negatively associated with the anti-TSST-1 antibody levels. Thus, both toxin exposure and HLA alleles affect the human antibody response to TSST-1.
Tissue sections, which are widely used in research and diagnostic laboratories and have already been examined by immunohistochemistry (IHC), may subsequently provide a resource for proteomic studies, even though only small amount of protein is available. Therefore, we established a workflow for tandem mass spectrometry-based protein profiling of IHC specimens and characterized defined brain area sections. We investigated the CA1 region of the hippocampus dissected from brain slices of adult C57BL/6J mice. The workflow contains detailed information on sample preparation from brain slices, including removal of antibodies and cover matrices, dissection of region(s) of interest, protein extraction and digestion, mass spectrometry measurement, and data analysis. The Gene Ontology (GO) knowledge base was used for further annotation. Literature searches and Gene Ontology annotation of the detected proteins verify the applicability of this method for global protein profiling using formalin-fixed and embedded material and previously used IHC slides.
The thyroid gland is both a thyroid hormone (TH) generating as well as a TH responsive
organ. It is hence crucial that cathepsin-mediated proteolytic cleavage of the precursor thyroglobulin
is regulated and integrated with the subsequent export of TH into the blood circulation, which is
enabled by TH transporters such as monocarboxylate transporters Mct8 and Mct10. Previously, we
showed that cathepsin K-deficient mice exhibit the phenomenon of functional compensation through
cathepsin L upregulation, which is independent of the canonical hypothalamus-pituitary-thyroid axis,
thus, due to auto-regulation. Since these animals also feature enhanced Mct8 expression, we aimed
to understand if TH transporters are part of the thyroid auto-regulatory mechanisms. Therefore,
we analyzed phenotypic differences in thyroid function arising from combined cathepsin K and
TH transporter deficiencies, i.e., in Ctsk-/-/Mct10-/-
, Ctsk-/-/Mct8-/y, and Ctsk-/-/Mct8-/y/Mct10-/-
.
Despite the impaired TH export, thyroglobulin degradation was enhanced in the mice lacking Mct8,
particularly in the triple-deficient genotype, due to increased cathepsin amounts and enhanced cysteine peptidase activities, leading to ongoing thyroglobulin proteolysis for TH liberation, eventually
causing self-thyrotoxic thyroid states. The increased cathepsin amounts were a consequence of
autophagy-mediated lysosomal biogenesis that is possibly triggered due to the stress accompanying
intrathyroidal TH accumulation, in particular in the Ctsk-/-/Mct8-/y/Mct10-/- animals. Collectively,
our data points to the notion that the absence of cathepsin K and Mct8 leads to excessive thyroglobulin
degradation and TH liberation in a non-classical pathway of thyroid auto-regulation.
Extracellular vesicles (EVs) are reminiscent of their cell of origin and thus represent a
valuable source of biomarkers. However, for EVs to be used as biomarkers in clinical practice, simple,
comparable, and reproducible analytical methods must be applied. Although progress is being
made in EV separation methods for human biofluids, the implementation of EV assays for clinical
diagnosis and common guidelines are still lacking. We conducted a comprehensive analysis of
established EV separation techniques from human serum and plasma, including ultracentrifugation
and size exclusion chromatography (SEC), followed by concentration using (a) ultracentrifugation,
(b) ultrafiltration, or (c) precipitation, and immunoaffinity isolation. We analyzed the size, number,
protein, and miRNA content of the obtained EVs and assessed the functional delivery of EV cargo.
Our results demonstrate that all methods led to an adequate yield of small EVs. While no significant
difference in miRNA content was observed for the different separation methods, ultracentrifugation
was best for subsequent flow cytometry analysis. Immunoaffinity isolation is not suitable for
subsequent protein analyses. SEC + ultracentrifugation showed the best functional delivery of
EV cargo. In summary, combining SEC with ultracentrifugation gives the highest yield of pure
and functional EVs and allows reliable analysis of both protein and miRNA contents. We propose
this combination as the preferred EV isolation method for biomarker studies from human serum
or plasma.
Genome-wide association studies (GWAS) are used to identify genetic markers linked with at least partially heritable diseases or phenotypes without prior knowledge of any disease-associated genetic loci. In summer 2008, all individuals of the population based cohort Study of Health in Pomerania (SHIP) were individually genotyped using the Affymetrix Genome-Wide Human SNP Array 6.0 microarray. The aim of this work was to establish an efficient workflow for GWAS using the more than 4000 individually genotyped samples of the SHIP cohort as well as pooled samples, focusing exclusively on analyzing genetic variations based on single nucleotide polymorphisms (SNPs). Firstly, an optimal array platform for the genotyping analysis had to be chosen that detected most of the available genetic variants at a high level of accuracy. Secondly, extensive quality controls had to be performed starting from DNA extraction and including tests of the generated array data by the analysis software to obtain the most reliable data for the subsequent association studies. For the identification of loci with smaller genetic influences, individual cohorts were meta-analyzed in large nationally and internationally organized consortia (e.g. CHARGE, BPGen, HaemGen, GIANT, CKD Gen). To participate in those meta-analyses, a comparable common set of genetic data had to be generated. This was done by imputation of the data generated by individual array-based genotyping on the basis of a reference panel using chromosomal linkage information. Due to the extensive phenotype information in the SHIP study, it was possible to perform many genome-wide discovery analyses and replication studies of possible susceptibility loci in a short time once the genetic data was available and processed. This resulted in the necessity to set up an efficient workflow for storing the huge amount of genetic data, converting it into different formats readable for specific analysis software, performing the association analyses and processing the results into a human-readable and clear format. This included replications, GWAS and meta-analyses of several cohorts. Many susceptibility loci were newly identified in different association studies with the SHIP data included and were subsequently published. In this work, genetic association studies with the SHIP data included were performed and published on blood pressure, uric acid concentrations, cardiac structure and function, lipid metabolism, hematological parameters, kidney functions, smoking quantity, circulating IGF-I and IGFBP-3 concentrations and thyroid volume including the risk of goiter development. Besides the SHIP cohort, there was a need to use other, especially patient cohorts for GWAS. Since no genotype information from these patient cohorts was available and the individual genotyping of many probands is still expensive and therefore often not affordable, we established the cost-effective allelotyping method that relied on pooling of DNA samples prior to the hybridization with microarrays. After estimating the pooling-specific error of a case-control allelotyping study, the allelotyping approach was used for identifying genetic susceptibility loci associated with aggressive periodontitis. If not referring to work of collaborators, all statistical analyses, data handling and in silico work concerning the SHIP data described in this context was performed by the author of this dissertation.
Staphylococcus aureus is a commensal that colonizes the skin and mucosa of 20-30% of the human population without leading to symptoms of diseases. However, it is also the most important cause of nosocomial infections. Those range from minor skin infections to life-threatening diseases such as pneumonia, endocarditis or septicaemia. Development of strains with resistance against many antibiotics complicates the situation further. The variety of strains with their various properties is one reason why no successful vaccine has been introduced to the market, yet. Therefore, efficient strategies for prevention and therapy of these dangerous infections are urgently needed. To accomplish these goals, the understanding of molecular interactions between host and pathogen is indispensable. Within this dissertation, several internalization experiments were performed aiming to investigate the interaction of S. aureus HG001 and human cell lines upon infection on the protein level. In order to obtain sufficient amounts of proteins for comprehensive physiological interpretations, it is necessary to enrich bacteria, secreted bacterial proteins or infected host cells upon internalization. In the framework of this thesis, bacteria which continuously produce green fluorescent protein (GFP) were employed. With that it was possible to sort bacteria from lysed host cells by flow cytometry or to separate host cells carrying bacteria after contact from those which did not. Subsequently, the proteins were proteolytically digested and peptides were analyzed by mass spectrometry in a gel-free proteomics approach. To allow such analyses also for staphylococci which do not produce GFP, such as clinical isolates, an additional protocol was developed. Prior to the infection, bacteria were labeled with fluorescent or para-magnetic nanoparticles. Afterwards bacteria could be separated from host cell debris by fluorescence-based cell sorting or with the help of a strong magnet. In order to cover also important secreted virulence factors of S. aureus HG001, phagosomes and engulfed bacteria and secreted proteins were isolated from infected host cells. Further steps of protocol optimization included improved bacterial cell counting by fluorescence-based flow cytometry, enhanced data analysis by combination of different search algorithms, and comprehensive functional annotation of proteins of the applied strain by sequence comparison with other strains and organisms. First, the proteome adaptation of internalized S. aureus HG001 and the infected A549 host cells was investigated during the first hours of infection. It became clear, that the bacteria replicate inside the host during the first 6.5 h. After internalization the levels of bacterial enzymes involved in protein biosynthesis decreased. Furthermore, bacteria adapted their proteome to the harsh intracellular conditions such as oxygen limitation, cell wall stress, host defense in terms of oxidative stress, and nutrient limitation. After contact to S. aureus HG001, A549 cells produced increased amounts of cytokines (e.g. IL-8, IFN-γ) in comparison to non-treated A549 cells. In addition, activation of the immunoproteasome and hints of early apoptosis activity were observed. Afterwards, the response of S. aureus HG001 to internalization by A549, S9 or HEK 293 cells was compared on the proteome level. It was obvious, that the adaptation to stress and the reduced protein synthesis are conserved mechanisms. Host dependent differences were detected especially in the energy metabolism and the synthesis of some amino acids. Additionally, bacteria showed different intracellular replication patterns depending on the host cell line. A higher percentage of extracellular bacterial proteins was found in isolated phagosomes compared to the sorted samples. Selected low abundant virulence factors could be quantified at two points in time after infection with the help of the sensitive single reaction monitoring (SRM) method. Further, a heterogeneous mixture of several phagosomal maturation steps was present during the first 6.5 h after infection. Finally, the gel-free proteome analyses could be applied to investigate Bordetella pertussis, the cause of whooping cough, during iron limitation and after internalization, and the results were compared to the S. aureus HG001 data.
Staphylococcus aureus (S. aureus) is the leading cause of serious diseases in human both from hospital and community associated infections. Some clinical manifestations of S. aureus infections are infective endocarditis (IE), osteoarticular infections, skin and soft tissue, pleuropulmonary, and device-related infections. In Germany, S. aureus is the second most common cause of hospital-acquired (HA) infections. About 16.7% of these nosocomial infections are caused by HA-MRSA clinical isolates. It has been a huge threat for the clinicians/scientists to control the emergence of such infections caused by S. aureus. S. aureus exhibits increasing virulence and resistance to various antibiotics, complicating prevention and treatment of infections. Eventually, active and passive vaccines might be the alternative strategy to deal with S. aureus related diseases. An effective S. aureus vaccine would provide great potential security and many societal benefits. However, so far vaccine trials have failed often due to limited number of available antigen candidates (monovalent/single antigen) in the clinical trials. Efforts to develop not only S. aureus vaccine but also prognosis or diagnosis tools are challenging tasks. That was the motivation point for the current thesis to identify potential antigen candidates for the aid of vaccine development using immunoproteomics approaches. From the earlier studies, passive immunisation with CP5, CP8, PNAG, ClfA, SdrG, alpha-hemolysin and active immunisation with IsdB, SEB, ClfA, CP5, CP8 were examined during preclinical trials and found to be the best examples for potential vaccine candidates. The antibody responses against S. aureus infections are heterogenous, still it is possible to identify the antibody signatures to a number of corresponding S. aureus antigens, whose abundance and presence could correlate to the disease state and may predict treatment outcome. To support this hypothesis, goals were set to develop and validate serological assay by indirect detection using suspension array technology (SAT). During the study, an antigen library of 140 recombinant S. aureus antigens was generated. Further serological assay were developed and validated to monitor the insights of antibody mediated humoral responses during S. aureus infection from various episodes of S. aureus infection. As an outcome, potential immunogenic antigen candidates were identified which may be used as candidates in active/passive vaccination and to stratify the patient. In total, three studies were carried out using serum and plasma samples from S. aureus nasal colonised healthy individuals (carriers and non-carriers) and bacteraemia patients (control, complicated and uncomplicated sepsis). Bead-based assays were performed and subsequent statistical analyses were done to identify immunogenic antigens that might discriminate between the different clinical status and outcome. Screening of healthy individuals (study-1) have shown significantly higher IgG responses against 14 antigens in S. aureus nasal carriers compared to non-carriers. Furthermore, the clonal complex 30 group of healthy carriers has shown significantly higher IgG responses against toxic shock syndrome toxin-1 (Tsst1) in comparison to non-clonal complex 30 healthy carriers. Study-2 have shown extensively higher IgG responses against 67 antigens in control samples compared to sepsis patients. 50% of the antigens eliciting different immune responses belonged to the extracellular components of S. aureus. The IgG responses against MSCRAMM proteins such as FnbA, FnbB, Efb-1 have been shown to be significantly higher in complicated sepsis. Study-3 have shown notably higher IgG responses against 8 antigens (Plc, SspB, IsaA, SEM, GlpQ, HlgC, SACOL0444, SACOL0985) at baseline in uncomplicated sepsis patients compared to patients subsequently developing complicated sepsis. In summary, the group of immunogenic antigens that have been identified in these studies using immunoproteomics approach could be a starting point for the development of S. aureus vaccines. Moreover, the suspension array technology approach facilitated the identification of new S. aureus antigen candidates in addition to earlier reports. The current results of this study support the hypothesis that it is possible to identify a serological response to potential S. aureus antigens that correlate to progression of S. aureus infections.
Deletions in the CCM1, CCM2, and CCM3 genes are a common cause of familial cerebral cavernous malformations (CCMs). In current molecular genetic laboratories, targeted next-generation sequencing or multiplex ligation-dependent probe amplification are mostly used to identify copy number variants (CNVs). However, both techniques are limited in their ability to specify the breakpoints of CNVs and identify complex structural variants (SVs). To overcome these constraints, we established a targeted Cas9-mediated nanopore sequencing approach for CNV detection with single nucleotide resolution. Using a MinION device, we achieved complete coverage for the CCM genes and determined the exact size of CNVs in positive controls. Long-read sequencing for a CCM1 and CCM2 CNV revealed that the adjacent ANKIB1 and NACAD genes were also partially or completely deleted. In addition, an interchromosomal insertion and an inversion in CCM2 were reliably re-identified by long-read sequencing. The refinement of CNV breakpoints by long-read sequencing enabled fast and inexpensive PCR-based variant confirmation, which is highly desirable to reduce costs in subsequent family analyses. In conclusion, Cas9-mediated nanopore sequencing is a cost-effective and flexible tool for molecular genetic diagnostics which can be easily adapted to various target regions.
Genomics is the field of modern biology that studies the genome as the sum of all genes of a given organism. Genomics includes the analysis of genomic variations in order to identify genetic susceptibility loci for various human diseases. Besides genomics, there are related fields summarized by the term "Omics" such as transcriptomics and proteomics, studying the sum of all transcripts and proteins in a defined biological system, respectively. Genetic variants, namely single nucleotide polymorphisms (SNPs) and copy number variations (CNVs) are used to identify genomic loci associated with human traits and diseases. Genome-wide association studies (GWASs) based on SNP data have been performed for a wide range of human traits and diseases. In the population-based Study of Health in Pomerania (SHIP) and the independent SHIP-TREND study, whole-genome genotyping data were available for 4081 and 986 individuals, respectively. In contrast to the widely used GWAS based on SNPs, association studies using CNV data are difficult to implement and thus less common. Therefore, one aim of this work was to detect CNVs using the whole-genome genotyping data available for 4081 individuals from SHIP. Another aim was to develop an efficient workflow for the analysis of these CNVs. As most common genetic variants exhibit only relatively small effects on phenotypic variability, large sample sizes are needed to maximize the statistical power to detect such effects. Therefore, the integration of data from multiple collaborating studies is indispensable. In this context, several CNV studies with the SHIP data have been performed and published, for example on body mass index (BMI) phenotypes where the SHIP cohort was used as a population-based control. Trait-associated genetic markers identified through GWASs are often intergenic or synonymous coding, and those loci identified through whole-genome CNV analyses often contain multiple genes, making it difficult to identify the causal variants. In this context, the functional analysis of identified loci aids in determining causal variant(s). One possibility to conduct functional analysis is the expression quantitative trait loci (eQTL) analysis, defined as the association of genome-wide genotyping data with genome-wide gene expression data based on measured transcriptomes. This allows the identification of genetic variants influencing the expression levels of defined genes. A further example are transcriptome-wide association analysis (TWAS), defined as the association of phenotype data with whole-genome expression data. Thus, another aim of this work was to establish an analysis pipeline for processing such expression data, which were available for about 1000 individuals from the SHIP-TREND study. Here, array-based gene expression data were generated using RNA prepared from whole-blood. Interpretation of TWAS results is often difficult, because of possible reverse causation on gene expression data. Furthermore, technical errors of measurement may bias the results. In a comprehensive work, biological and technical factors influencing measured gene expression data have been identified and were subsequently taken into account to improve the association analyses. To further elucidate the molecular mechanisms underlying the relationship of gene expression levels with human traits or diseases, pathway analyses using the Ingenuity Pathway Analysis (IPA) tool have been performed in connection with the TWAS. As for GWASs, the associations identified in TWAS usually exhibit only small effect sizes, highlighting the need for larger studies or meta-analysis to identify all susceptibility variants. In this context several eQTL- and TWAS meta-analyses using the SHIP-TREND data have been performed, for example on the phenotypes age, sex, BMI, smoking status and serum lipid traits. The results of these analyses are in preparation for publication and the most advanced example, the correlation of expression data with BMI, is presented here. The integration of whole-genome genotyping and expression data provides new functional information of the underlying biological mechanisms of complex human traits and diseases. Within the frame of this work, this could be demonstrated for the example of susceptibility to Helicobacter pylori infection.
The autism susceptibility locus on human chromosome 7q32 contains the maternally imprinted MEST and the non-imprinted COPG2 and TSGA14 genes. Autism is a disorder of the ‘social brain’ that has been proposed to be due to an overbalance of paternally expressed genes. To study regulation of the 7q32 locus during anthropoid primate evolution, we analyzed the methylation and expression patterns of MEST, COPG2, and TSGA14 in human, chimpanzee, Old World monkey (baboon and rhesus macaque), and New World monkey (marmoset) cortices. In all human and anthropoid primate cortices, the MEST promoter was hemimethylated, as expected for a differentially methylated imprinting control region, whereas the COPG2 and TSGA14 promoters were completely demethylated, typical for transcriptionally active non-imprinted genes. The MEST gene also showed comparable mRNA expression levels in all analyzed species. In contrast, COPG2 expression was downregulated in the human cortex compared to chimpanzee, Old and New World monkeys. TSGA14 either showed no differential regulation in the human brain compared to chimpanzee and marmoset or a slight upregulation compared to baboon. The human-specific downregulation supports a role for COPG2 in the development of a ‘social brain’. Promoter methylation patterns appear to be more stable during evolution than gene expression patterns, suggesting that other mechanisms may be more important for inter-primate differences in gene expression.
Staphylococcus aureus is a commensal colonizing 20-30% of the population as well as a pathogen causing diverse diseases ranging from skin infections via toxin mediated diseases to life threatening conditions. In its interplay with the human host, this microorganism resorts to an extensive repertoire of both membrane-bound and secreted virulence factors facilitating adhesion to, invasion of, and spreading into various host tissues. Among the numerous virulence factors produced by S. aureus are the staphylococcal superantigens (SAgs). They directly cross-link conserved regions of the T cell-receptor with MHC class II molecules (outside the peptide-binding cleft) on antigen presenting cells. This results in a strong stimulation of up to 20% of all T cells which respond with proliferation and massive cytokine release. Recently, the enterotoxin gene cluster (egc) located on a pathogenicity island was described. The egc-genes are the most prevalent SAg genes in commensal and invasive S. aureus isolates. However, they appear to cause toxic shock only very rarely and their presence is negatively correlated with severity of S. aureus sepsis. Therefore it was suggested that SAgs might differ in their pro-inflammatory potential. In addition to their superantigenicity, SAgs also act as conventional antigens and induce a specific antibody response. In contrast to non-egc SAgs, despite the high prevalence of egc SAgs, neutralizing antibodies against egc SAgs are very rare, even among carriers of egc-positive S. aureus strains. In order to find an explanation for this “egc-gap”, we have tested two non-exclusive hypotheses: (i) egc and non-egc SAgs have unique intrinsic properties and drive the immune response into different directions and (ii) egc and non-egc SAgs are released by S. aureus under different conditions, which shape the immune response to them. To test these hypotheses, we compared the effects of egc and non-egc SAgs on human blood cells. Their T cell-mitogenic potencies, the elicited cytokine profiles as well as their impact on gene expression were highly similar. Both egc and non-egc SAgs induced a very strong pro-inflammatory response. In contrast, the regulation of SAg release by S. aureus differed markedly between egc and non-egc SAgs. Egc-encoded proteins were secreted by S. aureus during exponential growth, while non-egc SAgs were released in the stationary phase. We conclude that the distinct biological behavior of egc and non-egc SAgs is not due to their intrinsic properties, which are very similar, but is caused by their differential release by S. aureus. Traditionally, S. aureus has not been considered as an intracellular pathogen but strong evidence emerged indicating that staphylococci can invade and persist in various cell types. Internalization might constitute a bacterial strategy to evade the host’s defense reactions and the action of antibiotics. The intracellular niche might thus constitute a reservoir for chronic or relapsing infections. Contrary to their potential importance, genome-wide functional genomics analyses of the adaptation reactions of S. aureus to the host cell environment are rare and so far confined to gene expression profiling. Investigations addressing the proteome of internalized S. aureus are still lacking due to the challenge of obtaining a sufficient number of infecting bacteria. The proteome of other pathogens such as Francisella tularensis has been characterized by classical 2-DE approaches. However, the number of bacteria required for such a 2-DE based approach is often exceeding the numbers available from in vivo infection models. Furthermore, this approach does not allow monitoring of time-dependent quantitative changes in protein levels. Here, a workflow allowing time-resolved analysis of internalized S. aureus by combining pulse-chase stable isotope labeling by amino acids in cell culture with high capacity cell sorting, on-membrane digestion, and high-sensitivity mass spectrometry is presented. This workflow permits detection and quantitative monitoring of several hundred staphylococcal proteins from as little as a few million internalized S. aureus cells. This approach has been used to reveal time-resolved changes in levels of proteins in S. aureus RN1HG upon internalization by human bronchial epithelial cells. Proteins involved in stress adaptation as well as protein folding and some components of the phosphotransferase system were upregulated in internalized staphylococci, whereas proteins of the purine biosynthesis pathway and tRNA aminoacylation were downregulated. Furthermore, regulatory adaptive responses of internalized S. aureus to the intracellular milieu were shown as global regulators displayed increased protein abundance levels compared to non-internalized bacteria. Taken together, we observed changes in levels of proteins with functions in protection against oxidative damage and adaptation of cell wall synthesis in internalized S. aureus.
The soil bacterium Bacillus subtilis is capable of surviving most of the ensuing environmental stress conditions. The dynamic nature of the soil habitat is manifested with varying amounts of nutrients, frequent flooding, drying and variation of other growth parameters like temperature, acidity, aeration etc. In order to survive in these conditions, B. subtilis has evolved to employ very complex adaptational responses. These adaptational responses are often multi-faceted; hence comprehensive understanding of the adaptational responses requires generation and integration of data on multi-omics level. Hence, multi-omics based detailed analysis was performed for the molecules involved in the central carbon metabolism (CCM) and proline biosynthesis pathway. In the current study two major stress conditions were extensively investigated: 1) energy limitation/starvation which is achieved by limiting glucose in the growth medium, 2) osmostress resulting from frequent drying out of soil which is simulated by adding 1.2 M NaCl to the growth medium. In addition to osmostress, the naturally available osmoprotectant glycine betaine (GB) was supplemented to understand the simultaneous influence of osmostress and osmoprotection on cellular physiology. To measure absolute protein abundances by mass spectrometry, a targeted approach (SRM –single reaction monitoring) using stable heavy isotope labeled artificial standard proteins known as QconCATs was optimized and implemented in the current study. The SRM technique in combination with QconCAT provided absolute quantitative data with high dynamic range for the 45 targeted CCM proteins. Transcriptome data was obtained from microarray analysis. The resulting data were integrated with the other omics data sets obtained by metabolome and flux analysis. As part of a joint study conducted by the BaCell-SysMO and BaSysBio consortia which aimed for the genome wide mapping of transcription units and previously unannotated RNAs of B. subtilis by means of tiling array hybridizations, mRNA samples from growth at high and low temperatures (51°C and 16°C) and in the presence of 1.2 M NaCl, shake flask experiments during transition from exponential growth to the stationary phase, and high density batch fermentation. Time course analysis of B. subtilis transitioning from exponential to stationary phase was investigated by high cell density fed-batch fermentation (glucose limitation) and batch fermentation (glucose exhaustion) with glucose as a limiting factor. A multi-omics analysis of the CCM for the batch fermentation was performed and the time course data was integrated and visualized. In conclusion, pathway based multi-omics data were generated, integrated and visualized as a prerequisite for systems biology approaches and for a better understanding of the complex adaptational responses of B. subtilis.
Heart Failure is currently the most common cardiac disorder and a major public health concern worldwide. The adult mammalian heart harbors a subpopulation of cardiac progenitor cells (CPC) that are capable of improving cardiac function. The scope of this study was to delineate the molecular phenotype of a subpopulation of CPCs characterized by the expression of the stem cells antigen-1 surface marker (Sca-1+) and to further identify molecular alterations occurring under heart failure conditions. In order to understand the underlying cellular mechanisms an integrated approach of proteomics and transcriptomics-based techniques were employed. The first step towards achieving this goal was to unravel the native Sca-1+ cell characteristics of freshly isolated progenitor cells derived from healthy adult murine hearts. The proteome map of Sca-1 cells was established using a gel-based mass-spectrometry (gel LC-MS/MS) approach. For better interpretation, a comparison with the protein profiles of cardiomyocytes and Sca-1- cells obtained under similar experimental conditions was performed. All three cell-types were morphologically different in size and structure, which was also evident from their protein expression profiles. We observed that Sca-1+ cells lack endothelial-like and cardiac contractile phenotypes, unlike Sca-1- cells and cardiomyocytes, respectively. Functional assessment of both protein and gene expression profiles revealed a possible role of Sca-1+ cells in cell adhesion, migration, and proliferation. CPC remain in a dormant state under physiological condition unless challenged by myocardial injury. Previous studies revealed that resident Sca-1+ cells home to the injured myocardium but not to the healthy heart and further differentiate into functional cardiomyocytes. We investigated the molecular background of this behavior of adult Sca-1+ cells under heart failure condition which might provide a better insight into their cardiogenic potential in a pathological milieu. The double transgenic α-myosin heavy chain (MHC)-cyclin T1/Gαq overexpressing mouse was chosen as a model for heart failure. Using the comparative gene expression profiling we could detect the differential regulation of 197 genes with at least a 2-fold difference. Among these BDNF mRNA levels were 5-fold higher in the Sca-1+ cells derived from transgenic mice (Cyc+) in comparison to that of wild-type controls (Wt+). This difference was also observed at protein level. The substantially higher expression of BDNF during heart failure prompted us to investigate its regulatory effect on Sca1+ cells. In this current study we were able to show that small amounts of exogenous BDNF stimulated the migratory potential of Cyc+ cells. This effect was not seen in treated Wt+ cells. Furthermore, pulsed SILAC was employed to monitor BDNF mediated changes following treatment. After BDNF treatment, 58 proteins were differentially regulated of which proteins related to cell proliferation were reduced in level in Cyc+ cells while they displayed increased levels in Wt+ cells. Findings from bromodeoxyuridine (BrdU) assays and immunoblotting indicated that BDNF might initiate a differentiation program by repressing cell proliferation in Cyc+ cells. Taken together, it could be shown that the BDNF effect on protein synthesis of Cyc+ and Wt+ cells varied considerably, suggesting an improvement of the cardiogenic potential of Sca-1+ cells under pathological conditions. Aldosterone levels are known to be elevated during heart failure. In this part of study it was hypothesized that endocrine factors associated with heart failure might influence the migration of CPC, thereby possibly restoring the cardiac function of diseased hearts. It could be shown that high concentrations of aldosterone, similar to those found in the plasma of heart failure patients, induced the migration of Sca-1+ cells by up to 60% when compared to control, while physiological levels had no significant influence. In addition, it could be demonstrated that the aldosterone stimulus led to the activation of the mineralocorticoid receptor (MR) expressed on Sca1+ cells, which in turn facilitated migration. This was supported by application of MR antagonist eplerenone, which significantly reduced the aldosterone-induced increase in cell migration while a glucocorticoid antagonist exhibited no inhibitory effect. Hence, the results support the potential role of aldosterone in the mobilization of CPC. It is currently believed that the beneficial effects of cell-based therapies on cardiac repair are imparted to a large degree via paracrine mechanisms. We therefore focused on understanding the influence of pathophysiological levels of aldosterone on the extracellular environment of Sca-1+ cells. MS-based secretome profiling of cells treated for 24h with aldosterone treatment revealed higher levels of proteins associated with extracellular matrix remodeling and IGF signaling. Additionally, galectin-1 and gelsolin were significantly increased in level under pathological conditions indicating a possible paracrine tissue repair of Sca-1+ cells. To conclude, the global proteome and transcriptome profiles generated here revealed the molecular phenotype of Sca-1+ cells which may be used for future reference. The comparative microarray study provided deeper insight into the endogenous changes in mRNA expression during heart failure and delineated the cardiogenic characteristics of Sca-1+ cells. Moreover, the data presented here shed new light on the potential role of BDNF in regulating the mobilization and proliferation of CPCs. Our study on the influence of aldosterone on the migration and the extracellular proteome of CPCs provided new insights on the beneficial effects of this mineralocorticoid on cardiac cells.
Non-Floating Harbour Syndrome (FLHS) neurodevelopmental disorder (NDD) is a recently described disorder caused by mutations in certain regions of the SRCAP gene. We generated two iPSC lines that contain truncating mutation on both alleles at the 3′-end of SRCAP using CRISPR/Cas9 technology. Both cell lines are pluripotent, differentiate into the 3 germ layers and contain no genomic aberrations or off-target modifications. The cell lines form part of a human disease model to investigate the effects of truncating mutations in different regions of SRCAP.
Impact of different oral treatments on the composition of the supragingival plaque microbiome
(2022)
Background
Antiseptics are used to inhibit oral biofilm growth. However, they affect not only pathogenic but also commensal bacteria, which are a natural barrier against oral diseases.
Objective
Using a metaproteome approach combined with a standard plaque-regrowth study, this pilot study examined the impact of different concentrations of lactoperoxidase (LPO)-system containing lozenges on early plaque formation, and active biological processes.
Design
Sixteen orally healthy subjects received four local treatments as a randomized single-blind study based on a cross-over design. Two lozenges containing components of the LPO-system in different concentrations were compared to a placebo and Listerine®. The newly formed dental plaque was analyzed by mass spectrometry (nLC-MS/MS).
Results
On average 1,916 metaproteins per sample were identified, which could be assigned to 116 genera and 1,316 protein functions. Listerine® reduced the number of metaprotein groups and their relative abundance, confirming the plaque inhibiting effect. The LPO-lozenges triggered mainly higher metaprotein abundances of early and secondary colonizers as well as bacteria associated with dental health but also periodontitis. Functional information indicated plaque biofilm growth.
Conclusion
The effects of Listerine® and LPO-system containing lozenges used for plaque inhibition are different. In contrast to Listerine®, the lozenges allowed maintenance of a higher bacterial diversity.
Medulloblastoma is one of the most common malignant childhood brain tumors. Although advances in multimodal treatment have significantly improved the survival rate, the outcome of children is still very poor. Therefore, there is an urgent need to develop novel approaches that can increase survival and reduce long term side effects of patients. Histone deacetylase inhibitors (HDIs) have emerged as a promising new class of antineoplastic agents in cancer therapy. Among them, suberoylanilide hydroxamic acid (SAHA, vorinostat, Zolinza®) is a highly potential HDI which has been approved for treatment of cutaneous T-cell lymphoma and is currently used for treatment of various tumor cell types both in vivo and in vitro. However, only little information has been reported on the effects of SAHA on primary central nervous system (CNS) tumors including medulloblastoma. The DAOY cell line represents the most widely used model cell line for investigation of medulloblastoma. In a recent study, it was reported that SAHA induces apoptosis and cell cycle arrest of DAOY cells (Sonnemann et al., 2006). However, the molecular mechanisms underlying this antitumor activity are still not clear. Therefore, in this study, effects of SAHA on DAOY cells were analysed at the protein level by using both gel-based and gel-free proteomic approaches. A 2D proteome reference map of DAOY cells in pH range of 4-7 was created from control and 10 µM SAHA treated cells via a combined analysis using 2D electrophoresis and MALDI-TOF/TOF-MS. This reference map covers 1196 identified protein spots of more than 770 distinct proteins. This is the first report of a 2D proteome map of SAHA treated DAOY cells. Moreover, the number of covered proteins was increased with the aid of a 1D-RP-LC-ESI-MS/MS analysis. Both methods together gave rise to a total of over 1200 distinct protein species, which is the largest catalogue of proteins identified in DAOY cells so far. In SAHA treated cells, a series of proteins were found to be subjected to protein degradation after treatment with the drug, including mainly cytoskeleton proteins (e.g. beta-tubulin, beta/gamma-actin, vimentin, filamin interacting protein 1), heat shock protein HS90B and a component of the FACT chromosomal remodelling complex (SSRP1). Most of those proteins are known substrates for caspases. Interestingly, several of these protein degradations are reported as typical apoptotic events in brain cells such as fragmentations of lamin A/C, alpha-spectrin, myosin-9 and SSRP1. The 2D reference map was then used as an annotated database for further investigation of changes in protein expression and protein modification profiles of DAOY cells following SAHA treatment. By using the 2D-DIGE technique, SAHA was found to induce significant changes in protein levels of DAOY cells, especially at the concentration of 10 µM while considerably fewer changes in the protein pattern were observed after treatment with the lower dose of 2 µM. Quantitative analysis of total protein extracts using the 2D-DIGE technique (employing pH range of 4-7) and spectral counting (employing a 1D-RP-LC separation) resulted in the identification of 213 differentially expressed proteins after treatment with 10 µM SAHA. Most of the targeted proteins belong to the groups of cytoskeleton proteins (e.g. lamin B1, calreticulin, dynexin), heat shock proteins (e.g. HSP71, HSP7C, CH60, GRP78) and brain signal transductors (e.g. 14-3-3E, 14-3-3T, CRK, MARCS). Other proteins that changed in levels after SAHA treatment include proteins involved in chromatin remodelling (e.g. RUBV1, RUBV2), transcription regulation (e.g. YBOX, CBX5), redox regulation (e.g. TXND4, TXND5, BIEA), metabolism (e.g. G6PI, K6PP, LDHB) and RNA processing (HNRP K). In addition, cathepsin D, one of autophagic executors, was increased by SAHA treatment while different subunits of the 26S proteasome complex were decreased in levels after addition of SAHA. Interestingly, we found alterations of mitochondrial proteins indicating the perturbation of mitochondrial function. VDACs are pore forming proteins located on the outer mitochondrial membrane which is known to play an important role in the release of apoptogenic proteins such as cytochrome-c from mitochondria to cytoplasm and induction of apoptosis. In this study, VDAC1 and VDAC3 were found to be overexpressed after incubation with SAHA, which might lead to an extensive release of apoptogenic proteins. This result is consistent with the study of Sonnemann and co-workers showing that SAHA induced the mitochondrial apoptotic pathway of DAOY cells (Sonnemann et al., 2006). Furthermore, these results are also in agreement with the previously known antitumor activities of SAHA reported for other cancer cell lines, e.g. the up-regulation of heat shock proteins, prostaglandin synthase 3, ubiquinol cytochrome c reductase or the down-regulation of MARCS proteins. …………………
Staphylococcus aureus can be a harmless colonizer of the human body, which colonizes about 20-30% of the population. If S. aureus overcomes the outer physical barrier of the body, comprised of the skin and mucous surfaces, it can also cause severe diseases such as endocarditis, pneumonia, or sepsis. S. aureus possesses a variety of secreted and surface bound virulence factors to mediate attachment and invasion into the host, to disseminate an infection and to modulate and evade the immune system. But not only the huge amount of virulence factors turn S. aureus into a dangerous human pathogen, also its resistances to a broad spectrum of commonly used antibiotics make infections hard to treat. During the last years it became apparent that S. aureus can be internalized by as well as replicate and persist in professional and non-professional phagocytic cells. It is suggested that the intracellular compartment protects S. aureus from antibiotic treatment and the immune system. To accomplish the adaptation to the intracellular compartment, S. aureus needs to regulate its gene expression by regulatory systems. One of these regulators is the alternative sigma factor SigB, which directly and indirectly regulates the expression of about 200 genes in vitro. However, the stimuli leading to the activation of SigB in S. aureus are barely known and also its role during an infection varies, depending on the S. aureus strain and infection model used. Therefore, the importance of SigB during the early adaption of S. aureus to the intracellular environment should be elucidated using a cell culture infection model. First, the existing cell culture infection workflow had to be modified to improve the data analysis and to increase the yield of identified proteins to comparatively monitor the adaption reaction of S. aureus HG001 and its isogenic ΔsigB mutant to the intracellular milieu of S9 human bronchial epithelial cells. The proteome analysis in conjunction with RT-qPCR analysis of the wild type and the ΔsigB mutant revealed a fast and transient activation of SigB directly after internalization. Quantitative analysis of the intracellular bacterial titer demonstrated a requirement of SigB for intracellular replication. Differences in the proteome composition of the ΔsigB mutant in comparison to the wild type after internalization reflected the different growth rates, resistance to antibiotics and toxic compounds, adaptation to oxidative stress, and protein quality control mechanisms. The accessory gene regulator (Agr) is like SigB also a global regulator of gene expression in S. aureus. To elucidate possible benefits in the intracellular survival of the co-occurrence of S. aureus wild type and Δagr mutant cells, like it can be found in sites of an infection, a co-infection assay was established. With the co-infection assay the simultaneous and competitive intracellular survival in comparison to the individual intracellular survival was followed for three days post-infection (p.i.). The single and the co-infection revealed that the wild type was able to replicate more efficiently during the first hours p.i. than the Δagr mutant, but the mutant was able to survive more efficiently. The extracellular proteome of S. aureus represents the key compartment for virulence factors. Virulence factors are secreted or bound to the surface of the S. aureus cell. With the infection workflow applied in this study, secreted proteins are lost during the enrichment of the intracellular bacteria for proteome analysis. Therefore, no information about the levels or the regulation of virulence factor expression can be acquired in the cell culture infection model using cell sorting approaches. Hence, the extracellular proteome of S. aureus was analyzed in vitro from shake flask experiments. To get a comprehensive overview of the regulatory impact of different global regulators onto the secretome, S. aureus LS1 mutants lacking the global regulators Agr, SarA and SigB were compared to the respective wild type. Additionally the protein level of the secretome of the well characterized and frequently used S. aureus strains 6850, CowanI, HG001, LS1, SH1000, and USA300 was comparatively analyzed. This project was performed in collaboration with the group of Prof. Löffler from the Institute of Medical Microbiology in Jena. The data of the extracellular proteome generated in this thesis were combined with phenotypic and toxicity data to explain strain differences in invasiveness, cytotoxicity, phagosomal escape, and intracellular persistence in infection experiments.
Dilated Cardiomyopathy is a chronic myocardial disease characterized by progressive depression of contractile function and ventricular dilatation. It is the leading cause of heart failure and the most common reason for heart transplantation. Besides genetic causes, viral infection and autoimmune response are considered to play a major role in the etiology of the disease. Among different viruses that cause the disease, Coxsackievirus B3 (CVB3) is predominantly associated with the development and progression of the disease. Moreover, Coxsackievirus induced myocarditis in the mouse mimics human myocarditis and dilated cardiomyopathy. In the murine model, the disease progresses over a period of 90 days from acute myocarditis to chronic myocarditis and further develops into dilated cardiomyopathy and congestive heart failure. Though much is known about the progression of the disease, the molecular events occurring after infection with CVB3 are not completely understood. In the current study, comparative proteomic analysis of A.BY/SnJ mouse hearts 84 days post infection (84 d p.i.) with CVB3 and age-matched non-infected mouse hearts was performed. 2D-DIGE and gel-free LC-MS/MS were used to characterize the changes occurring at the molecular level and Western Blot analysis as well as immunohistochemical staining was carried out for validation of results. A total of 101 distinct proteins were identified as displaying dilated cardiomyopathy-associated changes in A.BY/SnJ mouse hearts 84 d p.i. compared to age matched controls. Comprehensive analysis by both DIGE and gel-free proteomics revealed proteins related to lipid metabolism (18%), carbohydrate metabolism (14%), cell morphogenesis (14%) and respiratory electron transport chain (9%) to display significantly altered levels in diseased mouse hearts. The significant increase in extracellular matrix proteins observed in mouse hearts 84 d p.i. indicated extensive fibrosis. On the other hand, proteins related to energy metabolism were identified at lower levels in infected mouse hearts than in controls. These proteomics data and the decrease in activities measured for complexes I-IV of the respiratory electron transport chain in A.BY/SnJ mouse hearts 84 d p.i compared to age matched controls, indicate a diminished energy supply in the dilated hearts of CVB3 infected mice. Furthermore, proteins associated with muscle contraction were identified at lower levels in mouse hearts 84 d p.i. compared to age matched controls indicating compromised myocardial contractility due to virus induced dilated cardiomyopathy. While extracellular matrix proteins and contractile proteins were identified in the DIGE analysis, proteins of lipid metabolism which are mostly mitochondrial in origin and have a pI > 7 were identified by gel-free proteomics indicating the advantages of both methods. Gel based analysis also aided in the identification of protein isoforms/ species which allows conclusions on post translational modifications and protein processing. Thus, the current study also identified infection related changes in the phosphorylation of selected proteins. Phosphospecific staining of the gels demonstrated increased phosphorylation of myosin regulatory light chain - ventricular isoform, actin - aortic smooth muscle isoform, heat shock protein 90B, and heat shock protein beta-1 in infected mouse hearts. Extensive degradation of proteins was not observed in the dilated heart. As described earlier, virus induced dilated cardiomyopathy develops over a period of 90 days in the murine model during which the mice also grow and undergo aging. Since aging is one of the factors influencing the susceptibility of animals to disease, age dependent changes in the proteome of mouse hearts were also studied by comparing 4 months old (84d) A.BY/SnJ mice with 1 month old mice as controls. Complementary analyses by 2D-DIGE and gel-free LC-MS/MS analysis revealed 96 distinct proteins displaying age associated differences in intensity. These proteins are related to lipid metabolism (19%), protein transport (17%) and electron transport chain (12%). Mitochondrial proteins such as carnitine-o-palmitoyltranferase 1, carnitine-o-palmitoyltranferase 2, and carnitine-O-acetyltransferase involved in lipid metabolism and transport were identified at significantly higher levels indicating higher energy demand in 4 months old mice compared to controls. This conclusion is complemented by observation of decreases in the levels of respiratory electron transport chain proteins especially of subunits of ATP synthase as a member of complex V. Furthermore, an increase in intracellular transport proteins was also observed in 4 months old mouse hearts compared to one month old controls. An increase in the level of vesicular transport proteins likely constitutes a secondary effect leading to endoplasmic reticulum associated protein degradation. In the two studies described above, altered mitochondrial functioning and thereby decreased energy/ATP production was very prominent indicating the role of mitochondria in health and disease. The exchange of ADP/ATP across the mitochondrial membrane is carried out by the carrier protein adenine nucleotide translocase1 (ANT1). To improve understanding of the influence of ANT1 in the heart, comparative proteomic analysis using gel-free LC-MS/MS was performed with hearts of 3 months old rats over-expressing ANT1 using hearts from age-matched wild type animals as controls. A total of four hundred and thirty three proteins were identified with at least two peptides, of which eighty seven proteins displayed small but significant (p<0.05) changes in intensity. Proteins related to integrin linked kinase signalling and myocardial contraction displayed increased levels whereas proteins of the mitochondrial respiratory electron transport chain displayed decreased levels in ANT1 overexpressing hearts compared to wild type animals. Oxyblot analysis performed to study changes in the protein oxidation did not reveal any significant difference in the oxidative state of the proteins between the wild type and transgenic animals. To understand the influence of ANT1 overexpression in virus induced dilated cardiomyopathy, comparative proteomic analyses was performed for the mitochondrial fractions from the hearts of 8 months old rats of the wild type and ANT1 transgenic animals infected with CVB3. Of a total of 370 identified proteins, 83 proteins displayed altered levels in ANT1 overexpressing animals compared to controls. Proteins related to mitochondrial electron transport chain, fatty acid metabolism, contractility and cell structure displayed decreased levels in the infected transgenic animals compared to controls indicating decreased energy metabolism and myocardial contractility besides compromised cell structure. Besides viral causes of dilated cardiomyopathy, autoimmunity also plays a major role in the development of myocarditis and dilated cardiomyopathy. Therefore proteomic analyses of experimental models of autoimmune myocarditis generated by active immunization of rats with peptides of FcγIIa receptor -CEPPWIQVLKEDTVTL (peptide 1) designated as FcR animals and CRCRMEETGISEPI (peptide 2) designated as FcR2 animals- was performed. Of the 303 proteins identified with at least two peptides by gel-free LC-MS/MS analysis. 43 proteins displayed intensities greater than 1.2 fold in FcR rat hearts and 49 proteins displayed intensities greater than 1.2 fold in FcR2 rat hearts compared to animals injected with KLH adjuvant treated as controls. The majority of the alterations (>70%) were observed in both autoimmune models. Thus, immunization leading to an induction of the acute phase response signalling was observed in both experimental setups. Furthermore, the increased amount of proteins such as lumican or procollagen alpha 1, type 1 indicated the presence of fibrosis after immunization independent of the peptide used. In summary, using proteomics the current thesis addresses the changes in protein profiles of two models of dilated cardiomyopathy, namely, virus induced dilated cardiomyopathy and autoimmunity induced dilated cardiomyopathy in mouse and rat models of disease. 2D-DIGE and gel-free LC-MS/MS analysis are complementary techniques which provided a comprehensive view of the changes in the protein profile of hearts of the different animal models. Altered mitochondrial function resulting in decreased energy metabolism and compromised myocardial contractility were prominent in viral models of cardiomyopathy whereas intense acute phase response signalling was observed as a characteristic feature of autoimmune dilated cardiomyopathy. Altered mitochondrial function was also prominent in age associated changes in the heart of A.BY/SnJ mice indicating the role and influence of mitochondria in health and in disease.
In the post genomic era, novel “Omics” technologies like genomics and proteomics can be used in powerful screening approaches to provide unbiased lists of candidate genes and proteins and thus facilitate a comprehensive analysis of complex diseases such as cancer, which would not have been possible applying traditional genetic and biochemical approaches alone. During my PhD tenure I applied functional genomics screening technologies including proteomics in combination with traditional biochemical and cell biology approaches in two disease oriented projects: 1. Characterization of the role of BCL11b in Human T cell lymphomas (and) 2. Elucidation of the mechanism of pathophysiology of Johanson Blizzard Syndrome using UBR1 knockout mice and JBS patients’ lymphoblasts cell lines.
1.Characterization of the role of BCL11b in Human T cell lymphomas
: The Bcl11b protein belongs to the C2H2-family of Krueppel-like zinc finger proteins and thus is a member of the largest family of transcription factors in eukaryotes. It was shown to be important for a variety of functions such as T cell differentiation, normal development of central nervous system and DNA damage response. Malignant T cells undergo apoptotic cell death upon BCL11B down-regulation. However, the detailed mechanism of this cell death is not fully understood. Two dimensional difference in-gel electrophoresis (2D-DIGE), mass spectrometry and cell biological experiments were employed to investigate the functional impact of knock down of BCL11B in malignant T cell lines such as Jurkat and huT78. To further confirm the findings of these experiments, changes in protein patterns were also recorded after down-regulation of BCL11B expression in Jurkat cells over expressing BcL-xL and in Jurkat cells over expressing BCL11B. These experiments provide evidence for the involvement of the mitochondrial apoptotic pathway and increased levels of cleavage fragments of known caspase targets such as myosin, spectrin and vimentin were observed after BCL11B knockdown. The findings suggest an involvement of ERM proteins, which were up-regulated and phosphorylated upon BCL11B down-regulation. Besides ERM proteins, PDCD5, a key regulator of apoptosis, was also found at increased levels upon down regulation of BCL11B. Moreover, the levels of several proteins implicated in cell cycle entry, including DUT-N, UCK2, MAT1, CDK6, MCM4 and MCM6 were elevated, which might lead to uncontrolled cell cycle progression, uracil misincorporation and cell death. Interestingly, an inverse regulation pattern, i.e. decreased levels of ERM proteins, DUT-N, UCK2 and PDCD5 was seen upon over expression of BCL11B in Jurkat cells. In summary, proteome analyses revealed several previously unidentified mechanisms which could significantly contribute to the cell death following BCL11B knockdown.
2.Elucidation of the mechanism of pathophysiology of Johanson Blizzard Syndrome using UBR1 knockout mice and JBS patients’ lymphoblasts cell lines
: Johanson-Blizzard syndrome (JBS; OMIM 243,800), which was first described in 1971, is a rare autosomal recessively inherited genetic disorder with a unique combination of congenital abnormalities. The most constant clinical feature of JBS is the loss of exocrine pancreatic function due to progressive destruction of pancreatic acini. Genome wide linkage analysis identified the disease associated locus in the 15q14-q21 chromosome region and high-throughput sequencing of this region revealed several truncated and some missense mutations in the UBR1 gene. UBR1 gene contains 47 exons and spans over 161 kilobases. The UBR1 protein belongs to the E3 ubiquitin ligase family and is an important component of the N-end rule pathway of ubiquitous protein degradation. It was hypothesized that stabilization of direct and unique substrates of UBR1 could be the main cause of the JBS pathophysiology. So far sequencing of the UBR1 gene is the only available diagnostic procedure. However, sequencing might not always allow precise prediction of residual UBR1 activity. Hence, this study was started to develop a protein based diagnostic assay for the detection of subclinical cases of JBS and to identify signalling pathways contributing to the pathophysiology of this complex disorder using a murine UBR1 knockout model. 2D-DIGE proteome analysis was carried out for a comparative evaluation of lymphoblast samples of 14 patients and 11 controls. Principal component Analysis (PCA) clearly discriminated JBS patients from controls. However, 4 JBS patients differed from the rest and resembled controls more closely. Western-blot analysis revealed residual UBR1 levels in these patients, which were linked to a milder phenotype. Hierarchical clustering of the three groups (controls, patients with residual UBR1 levels and patients without UBR1) showed group-specific characteristic differences in the abundance of differentially regulated proteins. Quantification of a panel of five selected protein spots encompassing Interferon-induced GTP binding protein, HLA class II histocompatibility antigen, Annexin A6, FK506-binding protein 4 and GRP78 permitted discrimination of controls and JBS patients with mild phenotypes. Of note, the molecular chaperones GRP78 (BiP) and FK506BP were consistently altered in level in JBS patients and probably constitute UBR1 dependent substrates. This suggested JBS as an ER-stress related disease also indicating a possible way of therapeutic intervention. Comparative proteome analysis of UBR1 knockout and wild type animals after caerulein treatment revealed a significant accumulation of pancreatic proteases such as chymotrypsin B, anionic trypsin and pancreatic elastase in animals lacking UBR1. Furthermore, an up-regulation of ER-stress proteins and inflammation related proteins was observed. Phenotypic characterisation revealed in UBR1 knockout animals significantly increased lipase levels, a significantly increased histological score and significantly increased elastase activity 8h after the onset of pancreatitis. In isolated pancreatic acini of UBR1 knockout animals we found a significant increase in intracellular elastase activation upon supramaximal CCK stimulation, which was associated with a significant rise in the rate of necrosis explaining the more severe phenotype in the UBR1 knock-out animals. A TUNEL assay showed that there was more apoptosis in wild type compared to UBR1 knockout mice. Another set of experiments was designed to identify physiologically important substrates of UBR1. Inhibition of such substrates might then in turn allow reversion or prevention of the severe form of pancreatitis in UBR1 knockout mice. However, using the trypsin specific and reversible inhibitor S-124 it was shown that impaired trypsin degradation and thereby prolonged activation of this protease did not critically influence the phenotype. Calcium analysis after physiological stimulation revealed an increase of pathological Ca2+ signalling events, i.e. significant decrease of spike number and significant increase of spike duration. Of the candidates potentially influencing Ca2+ signalling RGS4 turned out to be of particular importance. Pre-incubation of pancreatic acini of UBR1 knockout animals with a specific RGS4 inhibitor (CCG-4986, 10 µM) normalized Ca2+ patterns, did not affect trypsin activity itself but prevented Ca2+-triggered premature trypsin activation and thus acinar disintegration. In summary, using lymphoblasts samples of JBS patients we were able to deduce a protein panel which could be developed as a possible diagnostic tool for confirmation of JBS syndrome. Furthermore, using UBR1 knockout mice in an experimental model we were able to elucidate the vital function of UBR1 and its direct substrate RGS4 in the defense against pathologic pancreatic damage thereby manifesting JBS as an inflammatory disorder due to an inadequate UBR1 mediated defense.
The soil living, Gram-positive bacterium Bacillus subtilis is frequently exposed to a wide variety of stress and starvation conditions in its natural environment. In order to survive under these environmental and energy stresses, the bacterium acquired a general stress response mechanism mediated by the alternative sigma factor, SigB. A wide-variety of stress conditions such as environmental stress conditions like ethanol stress, heat stress, oxidative stress, osmotic stress or limitation of glucose, oxygen, phosphate etc.; and low temperature growth induce this SigB-dependent general stress response. Though much is known about the mechanisms of activation of this general stress response, the conditions that induce the SigB regulon and its general functions, the definition of the structure of the SigB regulon is not completely clear. The SigB-dependent general stress regulon has previously been characterized by proteomic approaches as well as DNA-array based expression studies. Genome-wide expression studies performed by Price, Petersohn and Helmann defined the SigB regulon containing well above 100 target genes, however the overlapping list of target genes contains only 67 members. The differences between these studies probably result from the different strains, growth conditions, array platforms and experimental setups used in these studies. The first part of this work presents a targeted microarray analysis, which was performed to gain a better understanding of the structure of the general stress regulon. This is the first study analyzing the gene expression of a wild type strain and its isogenic sigB mutant strain for almost all known SigB inducing conditions, using the same array platform. Furthermore, the kinetics of the gene expression of 252 putative SigB-dependent genes and 36 appropriate control genes were recorded. The data were analyzed using Random Forest, a machine-learning algorithm, by incorporating the knowledge of previous studies. Two Random Forest models were designed in this study. The “expression RF” model was designed to identify genes showing expression differences between wild type and sigB mutant and the “kinetic RF” model to identify genes having a SigB-dependent expression kinetic, but is subject to secondary regulators next to SigB influencing their expression in the sigB mutant. The random forest classification using the “expression RF” model identified 166 genes as SigB regulon members based on the expression differences between the wild type and the sigB mutant strain. A variable importance plot showing the impact during the classification process within the “expression RF” could assign a hierarchy to the stress conditions investigated in this study. This hierarchy suggested all the RsbU-dependent environmental stresses to have higher impact on SigB-dependent gene expression compared to the RsbP-dependent energy stresses. The “kinetic RF” model identified 30 additional genes, having additional regulators next to SigB. The SigB dependency of the 30 genes identified by the “kinetic RF” model was validated by screening for SigB promoter motifs within the upstream region of these genes. The hierarchical clustering of the obtained motifs scores with the expression ratios of the SigB regulon members predicted in the current work revealed that only a subset of genes displayed correlation of gene expression values and sequence motifs. As this observation is not true for all sets of genes, it cannot be generalized that gene expression is only correlated with the corresponding motif scores. In total 196 SigB regulon members could be classified by this targeted oligo nucleotide microarray study. The majority of these regulon members were preceded by a putative SigB promoter motif either identified previously or predicted in the current work. The inclusion of the broad range of stress conditions, from environmental stresses to energy limiting conditions enabled a more detailed characterization of the structure of the general stress regulon of B. subtilis. The implementation of machine learning algorithms allowed the prediction with a minimum number of false-positives. In the second part of this work a high resolution tiling array analysis for the majority of growth conditions, stresses and changes in carbon sources supply was exploited for the screening for new SigB targets within already annotated or newly annotated RNA features. Thereby 133 previously un-annotated RNA features, which were completely new, were assigned to the SigB regulon. 50 of these 133 new features encode antisense RNAs which can have potential influence on the transcription / translation of their sense RNAs targets. A set of 282 annotated genes were indentified to be SigB regulon members, comparison with the targeted oligo nucleotide study, 90 genes were newly identified and not known to be SigB-dependent before. The analysis of the expression levels of these genes by k-means clustering revealed a cluster of 32 genes having low induction levels in all SigB-inducing conditions, although the majority of these genes possess a well-conserved SigB promoter motif. However, all these genes are probably subject to the control of regulators other than SigB, which might mask the typical strong SigB-dependent induction in the analyzed stress conditions. The analysis of the expression levels of the SigB regulon under a variety of conditions, revealed the SigB-dependent expression in conditions such as growth on plates, in swarming cells, biofilm formation and growth on glycerol as a carbon source. The possible reason for the induction of the SigB regulon during growth on plates and in swarming cells was supposed to be due to scarcity of the nutrients on plates, e.g. glucose limitation. SigB-dependent genes were likely induced during growth on glycerol due to the oxygen limitation that arose during the growth. However, induction of the SigB regulon during biofilm formation is assumed to be due to the phosphate limitation. The description of these new SigB activating stimuli gains support from the fact that the majority of the SigB-dependent genes were induced under these growth conditions. In addition to the general stress response, B. subtilis cells have stress specific adaptive mechanisms such as osmotic response, which was addressed in the third part of this dissertation. The frequent flooding and drying of the soil triggered osmotic stress, one of the most common stress conditions encountered by soil bacteria. Bacterial cells are equipped with osmo-specific adaptation responses in which specific regulation of a set of genes is used to maintain proper cellular function. It was known from previous studies that a large set of genes were influenced in expression by salt shock as well as growth at high osmolarity. Detailed analysis of the tiling array data revealed 467 differentially regulated newly annotated features during salt shock and 251 newly annotated features that were expressed at a different level during continuous growth at high versus low osmolarity. A comparison of the studies that used the sigB knockout mutant with the tiling array study also provided support for the sigma factor competition in control of the expression of osmo-adaptive genes. The level of induction of specific osmo-adaptive genes was much higher in the sigB mutant strain compared to the wild type strain. Furthermore, the tiling array data revealed a SigB-dependent antisense RNA S1290 upstream of the opuB operon that transports choline to the cell. The presence of this antisense RNA had a potential impact on the transcription of the opuB operon, during salt shock. In agreement with the previous studies, the tiling array data assigned the osmotically regulated proHJ operon to the SigE regulon, with a SigE promoter upstream. In addition, the significantly higher percentage of proline among spore coat proteins also supports the assumption that osmotic synthesis of proline might play a role during the generation of spores. In conclusion, the tiling array data revealed newly annotated RNA features that are regulated during the general stress response as well as the osmotic response of the cell. The current work identifies new conditions that induce the majority of SigB-dependent genes as well as the new features that regulate the osmotically induced genes.
Transfusion-related acute lung injury (TRALI) is an adverse transfusion reaction and the major cause of transfusion-related mortality. The syndrome occurs within six hours after transfusion and is characterized by acute respiratory distress and the occurrence of a non-cardiogenic, bilateral lung edema. TRALI is almost entirely induced by leukocyte-reactive substances which are present in the blood product and get transferred to the recipient during transfusion. The majority of cases (~80%) is caused by leukocyte-reactive immunoglobulins and is accordingly classified as immune-mediated TRALI. The responsible antibodies are generated via alloimmunization and are directed against human leukocyte antigens of class I and II or human neutrophil alloantigens (HNA). Within the HNA class, HNA-3a antibodies have an exceptional clinical relevance as they are most frequently involved in severe and fatal TRALI cases. The high mortality was associated with their characteristic ability to induce a strong neutrophil aggregation response. The described clinical relevance of HNA-3a antibody-mediated TRALI motivates the screening for new strategies for preventive or acute pharmacologic intervention. Knowledge of the molecular pathomechanisms is a crucial prerequisite and thus, respective investigations are required. In order to achieve this goal, HNA-3a antibody-induced cytotoxicity and aggregation were assessed on the molecular level by usage of flow cytometry, the granulocyte agglutination test and by phosphoproteome analysis. The current study provides insight into molecular processes during HNA-3a antibody-induced neutrophil responses and is the first to assess neutrophils using global, gel-free phosphoproteome analyses. Accordingly, it is the first to provide neutrophil phosphoproteome data in the context of TRALI. Gel-free phosphoproteome analyses of primary neutrophils required the highly selective and sensitive phosphopeptide enrichment from stable and sufficiently large protein extracts. However, an appropriate workflow did not exist and was hence developed by sequential protocol optimization steps. The developed workflow was finally proven suitable for comparative gel-free phosphoproteomics when detecting the formyl-methionyl-leucyl-phenylalanine-induced activation of extracellular signal-regulated kinase 1/2 (ERK1/2) signaling in a proof-of-principle experiment. The following single parameter analyses were conducted to investigate neutrophils for their responses to HNA-3a antibodies in absence and presence of proinflammatory priming conditions. Results revealed that the direct stimulation of neutrophils with HNA-3a antibodies will likely not cause the induction of cytotoxic effector functions. In contrast, neutrophils react predominantly by aggregation, a process which is potentially mediated by integrins and causes a secondary, subthreshold activation of solely ERK2. Accordingly, only the neutrophil aggregation response could also be enhanced by an appropriate priming. Taken together, the single parameter analyses proved neutrophil aggregation as the main pathomechanism in HNA-3a antibody-mediated TRALI and thus, the underlying signaling pathways were investigated by global, gel-free phosphoproteomics. The following phosphoproteome analyses indicated the induction of a biphasic signaling during 30 minutes of HNA-3a antibody treatment and signaling pathways of Rho family GTPases could be associated with the first and the second phase. Additionally, the involvement of ERK signaling was indicated in the second phase and this result corroborated thus the data of the previous single parameter analyses. The comprehensive analysis of the identified signaling pathways revealed Rho, Rac and Cdc42 as central regulators and the specific inhibition of Rho in the following validating experiments led very intriguingly to a significant enhancement of HNA-3a antibody-mediated neutrophil aggregation. Hence, this result indicated a potential inhibitory effect of HNA-3a antibodies on Rho activity. Therefore, Rho inhibition was suggested to occur in parallel to an adhesion-inducing signaling pathway and might hence be involved in the stabilization of neutrophil aggregates in HNA-3a antibody-induced TRALI. The results from this doctoral thesis contributed to the generation of a new pathogenesis model for HNA-3a antibody-mediated TRALI. In this model, neutrophils respond to direct HNA-3a antibody exposure predominantly by homotypic aggregation. These potentially very stable and primed aggregates accumulate in the lung and are susceptible to parallel, proinflammatory stimulation. Subsequently, this cascade leads to full neutrophil activation and finally to TRALI induction.
Cerebral cavernous malformations are slow-flow thrombi-containing vessels induced by two-step inactivation of the CCM1, CCM2 or CCM3 gene within endothelial cells. They predispose to intracerebral bleedings and focal neurological deficits. Our understanding of the cellular and molecular mechanisms that trigger endothelial dysfunction in cavernous malformations is still incomplete. To model both, hereditary and sporadic CCM disease, blood outgrowth endothelial cells (BOECs) with a heterozygous CCM1 germline mutation and immortalized wild-type human umbilical vein endothelial cells were subjected to CRISPR/Cas9-mediated CCM1 gene disruption. CCM1
−/− BOECs demonstrated alterations in cell morphology, actin cytoskeleton dynamics, tube formation, and expression of the transcription factors KLF2 and KLF4. Furthermore, high VWF immunoreactivity was observed in CCM1
−/−
BOECs, in immortalized umbilical vein endothelial cells upon CRISPR/Cas9-induced inactivation of either CCM1, CCM2 or CCM3 as well as in CCM tissue samples of familial cases. Observer-independent high-content imaging revealed a striking reduction of perinuclear Weibel-Palade bodies in unstimulated CCM1
−/−
BOECs which was observed in CCM1
+/− BOECs only after stimulation with PMA or histamine. Our results demonstrate that CRISPR/Cas9 genome editing is a powerful tool to model different aspects of CCM disease in vitro and that CCM1 inactivation induces high-level expression of VWF and redistribution of Weibel-Palade bodies within endothelial cells.
Vector-based SARS-CoV-2 vaccines have been associated with vaccine- induced thrombosis with thrombocytopenia syndrome (VITT/TTS), but the causative factors are still unresolved. We comprehensively analyzed the ChAdOx1 nCoV-19 (AstraZeneca) and Ad26.COV2.S (Johnson and Johnson) vaccines. ChAdOx1 nCoV-19 contains significant amounts of host cell protein impurities, including functionally active proteasomes, and adenoviral proteins. A much smaller amount of impurities was found in Ad26.COV2.S. Platelet factor 4 formed complexes with ChAdOx1 nCoV-19 constituents, but not with purified virions from ChAdOx1 nCoV-19 or with Ad26.COV2.S. Vascular hyperpermeability was induced by ChAdOx nCoV-19 but not by Ad26.COV2.S. These differences in impurities together with EDTAinduced capillary leakage might contribute to the higher incidence rate of VITT associated with ChAdOx1 nCoV-19 compared to Ad26.COV2.S.
Abstract
Streptococcus pneumoniae infections are a leading cause of death worldwide. Bacterial membrane vesicles (MVs) are promising vaccine candidates because of the antigenic components of their parent microorganisms. Pneumococcal MVs exhibit low toxicity towards several cell lines, but their clinical translation requires a high yield and strong immunogenic effects without compromising immune cell viability. MVs are isolated during either the stationary phase (24 h) or death phase (48 h), and their yields, immunogenicity and cytotoxicity in human primary macrophages and dendritic cells have been investigated. Death‐phase vesicles showed higher yields than stationary‐phase vesicles. Both vesicle types displayed acceptable compatibility with primary immune cells and several cell lines. Both vesicle types showed comparable uptake and enhanced release of the inflammatory cytokines, tumor necrosis factor and interleukin‐6, from human primary immune cells. Proteomic analysis revealed similarities in vesicular immunogenic proteins such as pneumolysin, pneumococcal surface protein A, and IgA1 protease in both vesicle types, but stationary‐phase MVs showed significantly lower autolysin levels than death‐phase MVs. Although death‐phase vesicles produced higher yields, they lacked superiority to stationary‐phase vesicles as vaccine candidates owing to their similar antigenic protein cargo and comparable uptake into primary human immune cells.
There is growing evidence for sex and gender differences in the clinical manifestation and outcomes of human diseases. Human primary endothelial cells represent a useful cardiovascular model to study sexual dimorphisms at the cellular level. Here, we analyzed sexual dimorphisms of the secretome after serum starvation using human umbilical vein endothelial cells (HUVECs) from twin pairs of the opposite sex to minimize the impact of varying genetic background. HUVECs were starved for 5 and 16 h, respectively, and proteins of the cell culture supernatants were analyzed by tandem mass spectrometry. Altogether, 960 extracellular proteins were identified of which 683 were amendable to stringent quantification. Significant alterations were observed for 455 proteins between long-term and short-term starvation and the majority were similar in both sexes. Only 5 proteins showed significant sex-specific regulation between long-versus short-term starvation. Furthermore, 19 unique proteins with significant sexual dimorphisms at the same time points of serum starvation were observed. A larger number of proteins, for example tissue factor inhibitor 2 (TFPI2), displayed higher levels in the supernatants of females compared to male cells after long term serum starvation that might point to higher adaptation capacity of female cells. The overall results demonstrate that male and female cells differ in their secretome.
Humanity is plagued by many diseases. Beside environmental influences, many --- if not all --- diseases are also subject to genetic predisposition and then display molecular alterations such as proteomic or metabolic aberrations. The elucidation of the molecular principles underlying human diseases is one of the prime goals of biomedical research. To this end, there has been an advent of large-scale omics profiling studies. While the field of molecular biology has experienced tremendous development, data analysis remains a bottleneck. In the context of this thesis, we developed a number of analysis strategies for different types of omics data resulting from different experimental settings. These include approaches for associations studies for plasma miRNAs and time-resolved plasma omics data. Furthermore, we devised analyses of different RNA-Seq transcriptome profiling studies coping with problems such as lack of replicates or multifactorial experimental design. We also designed machine learning frameworks for the identification of discriminatory biomolecular signatures analysing case-control or time-to-event data. All of the strategies mentioned above were developed and applied in the contexts of multi-disciplinary endeavours. They aided in the identification of plasma miRNAs associated with age, sex, and BMI as well as plasma miRNAs bearing potential as diagnostic biomarkers for non-alcoholic fatty liver disease (NAFLD). This thesis significantly contributed to a study demonstrating the utility of plasma miRNAs as prognostic biomarkers for major cardiovascular events such as ST-elevation myocardial infarction. Our approaches for analysing RNA-Seq data aided in the characterisation of murine models for Alzheimers disease and the transcriptional response of human gingiva fibroblasts to ionizing radiation exposure. Furthermore, the developed approaches were applied for studying a human model for thyrotoxicosis and for the successful identification of a multi-omics plasma biomarker signature of thyroid status. We are only beginning to understand the molecular principles underlying human diseases. The approaches and results presented in this thesis will contribute to improved understanding of biomolecular processes involved in common diseases such as Alzheimers disease, NAFLD, and cardiovascular diseases.
Infektionen durch Staphyloccocus aureus können aufgrund zunehmender Therapieresistenz (ca-MRSA, ha-MRSA, la-MRSA etc.) gravierende Verläufe nehmen und stellen nicht nur eine wachsende medizinische, sondern auch eine gesundheitsökonomische Herausforderung im Patientenmanagement dar. Für die Entwicklung innovativer Behandlungsstrategien ist die genaue Analyse der keimspezifischen Infektionsmechanismen eine wichtige Voraussetzung. S. aureus verwendet sogenannte Virulenzfaktoren um einen zunächst lokalen Infektionsherd zu etablieren. Wachstumsphasenabhängig werden z.B. Adhäsine, Kapselantigene oder Toxine exprimiert, um dann gezielt im Infektionsgeschehen eingesetzt zu werden. In den vergangenen Jahren konnten wichtige Fortschritte zur Ermittlung infektionsrelevanter stammspezifischer Regulationsmechanismen bei S. aureus gemacht werden. Ziel dieser Arbeit war zunächst eine Datengrundlage zur Untersuchung der Wirt-Erreger-Interaktion durch Proteomreferenzkarten von humanen S9-Epithelzellen zu schaffen. Zudem wurden die extrazellulären Expressionsmuster von S. aureus-Isolat NCTC8325-4 in verschiedenen Kulturmedien analysiert, um ein geeignetes Medium für die Kokultur der Wirts –wie auch der Erregerzellen entwickeln. Weiterhin sollte eine Proteomreferenzkarte der extrazellulären Proteinfraktion von S.aureus RN1HG erstellt werden, um eine anschließende Vergleichsanalyse der wachstumsphasenabhängigen Expressionsprofile zu ermöglichen. Zur Erstellung der Proteomreferenzkarten wurden die Proteingemische mit einer zweidimensionalen Gelelektrophorese (2D PAGE) aufgetrennt. Zuerst wurden die Proteine einer isoelektrischen Fokussierung unterworfen (IPG – Streifen 24cm für pI 4-7; 11cm u. 18cm für pI 6-11) und dann in der zweiten Dimension nach ihrer Größe mit 12,5% SDS Polyacrylamidgelelektrophorese separiert (Trennbereich 20 -120 kD). Die Proteinspots wurden mit verschiedenen Färbemethoden (Silbernitrat, kolloidales Coomassie Brillantblau oder Flamingo Fluoreszenzfärbung) dargestellt. Mit MALDI-TOF wurden die Proteine sequenziert und quantifiziert. Die gefundenen Sequenzen wurden durch Datenbanksuche (Mascot 2.0; SwissProt 55.1_human/all) identifiziert. Auf Wirtsseite sollten die humanen S9-Epithelzellen (CFTR repaired IB3-1) als Modell einer bakteriellen Atemwegskolonisation dienen, dabei wurden sie in MEM (mit 4% FCS, 1% NEAA (non essential amino acids) und 4 mM L-Glutamin) kultiviert. Auf der Erregerseite wurden die S. aureus - Isolate NCTC8325-4 (11-bp deletion in rsbU, cured of three prophages) und RN1HG (rsbU restored) (HG001; Herbert S. et al, 2010) verwendet . Proteomreferenzkarten für den pI Bereich pI 4-7 und pI 6-11 wurden für das Proteom der S9-Epithelzellen angefertigt. Es wurden 668 Einzelproteine (508 mit Proteinscore >55) identifiziert und funktionell via Datenbanksuche (www.pantherdb.org) charakterisiert. Somit können infektionsassoziierte Veränderungen im Proteinmuster der S9-Wirtszellen erkannt und valide ausgewertet werden. Um eine Kokultur für Internalisierungsversuche von S.aureus und den S9-Epithelzellen zu ermöglichen, wurde eine methodenoptimierende Kultivierungsreihe (MEM mit und ohne 5%FCS, RPMI 1640, TSB) mit dem Laborstamm NCTC8325-4 durchgeführt. Der Datenvergleich der extrazellulären Expressionsmuster trug zur Entwicklung eines geeigneten Kulturmediums (MEM mit 2mM AS supplementiert) bei. S. aureus RN1HG wurde in diesem Medium kultiviert und von der extrazellulären Proteinfraktion wurde eine Proteomreferenzkarte im Bereich pI 4-7 angefertigt. Es konnten 91 Einzelproteine (48 mit Proteinscore >55) identifiziert werden. Durch eine vergleichende Analyse konnten Veränderungen der Proteinmuster innerhalb verschiedener Wachstumsphasen (exponentiell, transient, stationär und spät stationär) detektiert und ein optimaler Erntezeitpunkt festgelegt werden. Während der exponentiellen Wachstumsphase waren typischerweise kolonisationsrelevante Proteine (LytM, SAOUHSC_02979, SceD), in der stationären Phase vorrangig invasionsrelevante (SsaA, IsaA, SspB) angereichert. Somit konnten charakteristische Expressionsmerkmale bei S. aureus RN1HG nachgewiesen werden, welche den weiteren Einsatz gemeinsam mit den S9-Epithelzellen ermöglichen (Schmidt F. et al., 2010).
Staphylococcus aureus ist ein ubiquitär verbreitetes Bakterium. Häufig als Kommensale des Menschen vorkommend, zählt das Bakterium jedoch zu einem der wichtigsten Infektionserreger des 21. Jahrhunderts. Neben lokalen Infektionen (z. B. Furunkel) kann der Erreger nach einer Besiedlung auch systemische Erkrankungen in seinem Wirt (z. B. Sepsis, Endokarditis, Pneumonie) hervorrufen. Die pathogene Wirkung von S. aureus ist auf die Produktion und Sekretion von Pathogenitäts- bzw. Virulenzfaktoren, unter anderem Superantigene, hämolytische Toxine, Gewebe-zerstörende Enzyme und Oberflächenproteine, welche ihrerseits mit dem Immunsystem des Wirtes interferieren, zurückzuführen. Ziel dieser Arbeit war unter anderem die Analyse des extrazellulären Proteoms von S. aureus RN1HG in pMEM, ein an das bakterielle Wachstum adaptierte Zellkulturmedium. Bei den extrazellulären Proteomanalysen von S. aureus RN1HG konnten 39 Proteine identifiziert werden, welche dem Bakterium eine Interaktion mit dem Wirt (Clumping-Faktoren) ermöglichen, die Phagozytose (Protein A) verhindern oder die Ausbreitung im Gewebe (alpha-Hämolysin, gamma-Hämolysin, Lipase) erleichtern. Da die Zusammensetzung des extrazellulären Proteoms durch diverse Regulons (z. B. agr-System, sarA, sigB) bestimmt wird, stellte sich die Frage, inwiefern diese einen Einfluss auf die Virulenz des Stammes RN1HG-Stamm haben. Ein vielfach in der Literatur diskutierter Regulator ist SigB. Die vergleichende gelfreie LC-MS/MS-Analyse des extrazellulären Proteoms von S. aureus RN1HG mit einer sigB Deletion (RN1HG delta sigB) zeigte, dass sich im Vergleich zum Wildtyp die Zusammensetzung des extrazellulären Proteoms nicht grundsätzlich ändert. Jedoch konnte durch eine „labelfreie“ Quantifizierung eine verstärkte Akkumulation zahlreicher Virulenzfaktoren (z. B. Aureolysin, 1-Phosphatidylinositol- Phosphodiesterase, alpha-Hämolysin, gamma-Hämolysin, Lipase, Thermonuklease) in der delta sigB Mutante nachgewiesen werden. Die Serin-Proteasen A, C und E konnten nur für die delta sigB Mutante identifiziert werden. Adhäsine, darunter Clumping-Faktoren oder Elastin-Bindeprotein, wurden lediglich während der exponentiellen Wachstumsphase für die delta sigB Mutante nachgewiesen. Dies konnte für clf auch durch Transkriptomanalysen belegt werden. Die gelfreien Analysen wurden durch gelbasierte Verfahren (2D-Gelelektrophorese) ergänzt. Neben der Erstellung einer Referenzkarte des extrazellulären Proteoms von S. aureus RN1HG (Wildtyp und delta sigB Mutante) wurden quantitative gelbasierte Daten erhoben, die einerseits die Ergebnisse der gelfreien Analysen bestätigten, andererseits aber auch zeigten, dass SigB nur wenig Einfluss auf die Prozessierung und posttranslationale Modifikation extrazellulärer Proteine in S. aureus RN1HG hat. Die Zusammensetzung des extrazellulären Proteoms ist vor allem bei pathogenen Bakterien bedeutsam, da z. B. durch extrazelluläre Enzyme die Erschließung von Nährstoffquellen in extremen Habitaten begünstigt und durch Virulenzfaktoren sowohl die Kolonisierung als auch die Überlebensfähigkeit im Wirtsorganismus gesichert wird. Um die Erreger-Wirt Interaktion näher zu charakterisieren, wurde die Reaktion von humanen bronchialen Epithelzellen (S9-Zellen) auf eine Infektion mit S. aureus RN1GH pMV158 untersucht. Die Durchführung der Infektionsstudien mit einem GFP-markierten RN1HG-Stamm ermöglichte die Sortierung der infizierten S9-Zellen durch die Durchflusszytometrie. Da im Epithelverband nicht jede Zelle mit S. aureus infiziert ist, lag der Vorteil der Sortierung darin, dass Proteomanalysen spezifisch für die S9-Zellen mit internalisierten Staphylokokken durchgeführt werden konnten. Infolge einer Internalisierung von S. aureus durch die S9-Epithelzellen kam es zunächst zu einer Integrin-vermittelten Adhäsion. Eine zunehmende Inkubation mit S. aureus führte zu inflammatorischen Prozessen. Die Invasion pathogener Bakterien in Wirtzellen führt somit zum Remodelling biologischer Prozesse, die dem Wirt die Auseinandersetzung mit dem Pathogen ermöglichen.
Die vorliegende Arbeit adressiert die Nutzbarkeit des humanen Speichelproteoms als diagnostisches Instrument im Kontext einer oralen Mukositis bei Kopf- und Halskarzinoms. Als häufigste Nebenwirkung einer Radio(chemo)therapie kann die Mukositis therapielimitierend sein und hat für betroffene Patienten meist eine Einschränkung ihrer Lebensqualität zur Folge. Trotz der guten Verfügbarkeit von Speichel existieren wenige Studien, welche zeigen, dass das Speichelproteom für die Diagnostik einer Krankheit oder zur Therapieentscheidung nutzbar ist. Das hat unter anderem seinen Grund in der Komplexität der massenspektrometrischen Methode. Die erste Veröffentlichung (Golatowski et al. 2013) erarbeitete deshalb einen Standard in der Probengewinnung von Speichel. Als Ergebnis steht die Empfehlung zur Nutzung eines Paraffin-Kaugummis, aufgrund des hohen Speichelvolumens und der guten Vergleichbarkeit mit der nichtstimulierten Salivation beim identifizierten Proteom. In einer zweiten Veröffentlichung (Jehmlich & Golatowski et al. 2014) wurden C18 Mikrosäulen verschiedener Hersteller bezüglich ihres Einflusses auf die Proteinidentifizierung verglichen. Die Säulen sind notwendig für die Entsalzung und Aufreinigung eines Peptidgemisches. Mit allen verwendeten Säulen konnten ähnliche Ergebnisse erzielt werden, wobei die ZipTip® µC18 sowie C18 Systeme der OASIS® HLB μElution 96er Well Platte und TopTip® C18 Pipettenspitzen leicht überlegen sind. In der letzten Arbeit (Jehmlich et al. 2015) wurden die gewonnenen Erkenntnisse genutzt, um die Speichelproben von Patienten mit Kopf- und Halskarzinom zu untersuchen. Insgesamt zeigten wir die Möglichkeit, alterierte Proteine zwischen zwei Patientengruppen massenspektrometrisch zu detektieren. Mit den gefundenen Daten konnte demonstrieren werden, dass massenspektrometrische Techniken geeignet sind, um schon vor Behandlungsbeginn Patienten zu identifizieren, die für die Entwicklung einer oralen Mukositis prädisponiert sind. Es ist hierbei die Proteinklasse der Metalloproteinasen hervorzuheben, da diese für einen therapeutischen Ansatz gegen Mukositis interessant sind. In Zukunft werden jedoch größere und voraussichtlich multizentrische Studien erforderlich sein, um ausreichend große Patientenkohorten zusammenzustellen und die Klassifikation speziell für Patienten ohne Mukositisrisiko sensitiver zu gestalten.
Functional Redundancy and Specialization of the Conserved Cold Shock Proteins in Bacillus subtilis
(2021)
Abstract
Introduced populations of invasive organisms have to cope with novel environmental challenges, while having reduced genetic variation caused by founder effects. The mechanisms associated with this “genetic paradox of invasive species” has received considerable attention, yet few studies have examined the genomic architecture of invasive species. Populations of the heart node ant Cardiocondyla obscurior belong to two distinct lineages, a New World lineage so far only found in Latin America and a more globally distributed Old World lineage. In the present study, we use population genomic approaches to compare populations of the two lineages with apparent divergent invasive potential. We find that the strong genetic differentiation of the two lineages began at least 40,000 generations ago and that activity of transposable elements (TEs) has contributed significantly to the divergence of both lineages, possibly linked to the very unusual genomic distribution of TEs in this species. Furthermore, we show that introgression from the Old World lineage is a dominant source of genetic diversity in the New World lineage, despite the lineages' strong genetic differentiation. Our study uncovers mechanisms underlying novel genetic variation in introduced populations of C. obscurior that could contribute to the species' adaptive potential.
Differences in Mouse Hepatic Thyroid Hormone Transporter Expression with Age and Hyperthyroidism
(2015)
Background: Clinical features of thyroid dysfunction vary with age, and an oligosymptomatic presentation of hyperthyroidism is frequently observed in the elderly. This suggests age modulation of thyroid hormone (TH) action, which may occur, for example, by alterations in TH production, metabolism and/or TH action in target organs. Objectives: In this paper, we address possible changes in TH transporter expression in liver tissues as a mechanism of age-dependent variation in TH action. Methods: Chronic hyperthyroidism was induced in 4- and 20-month-old C57BL6/NTac male mice (n = 8-10) by intraperitoneal injections of 1 µg/g body weight <smlcap>L</smlcap>-thyroxine (T<sub>4</sub>) every 48 h over 7 weeks. Control animals were injected with PBS. Total RNA was isolated from liver samples for analysis of the TH transporter and TH-responsive gene expression. TH concentrations were determined in mice sera. Results: Baseline serum free T<sub>4</sub> (fT<sub>4</sub>) concentrations were significantly higher in euthyroid young compared to old mice. T<sub>4</sub> treatment increased total T<sub>4</sub>, fT<sub>4</sub> and free triiodothyronine to comparable concentrations in young and old mice. In the euthyroid state, TH transporter expression was significantly higher in old than in young mice, except for Mct8 and Oatp1a1 expression levels. Hyperthyroidism resulted in upregulation of Mct10, Lat1 and Lat2 in liver tissue, while Oatp1a1, Oatp1b2 and Oatp1a4 expression was downregulated. This effect was preserved in old animals. Conclusion: Here, we show age-dependent differences in TH transporter mRNA expression in the euthyroid and hyperthyroid state of mice focusing on the liver as a classical TH target organ.
Background: Tissue-resident macrophages have mixed developmental origins. They derive in variable extent from yolk sac (YS) hematopoiesis during embryonic development. Bone marrow (BM) hematopoietic progenitors give rise to tissue macrophages in postnatal life, and their contribution increases upon organ injury. Since the phenotype and functions of macrophages are modulated by the tissue of residence, the impact of their origin and developmental paths has remained incompletely understood. Methods: In order to decipher cell-intrinsic macrophage programs, we immortalized hematopoietic progenitors from YS and BM using conditional HoxB8, and carried out an in-depth functional and molecular analysis of differentiated macrophages. Results: While YS and BM macrophages demonstrate close similarities in terms of cellular growth, differentiation, cell death susceptibility and phagocytic properties, they display differences in cell metabolism, expression of inflammatory markers and inflammasome activation. Reduced abundance of PYCARD (ASC) and CASPASE-1 proteins in YS macrophages abrogated interleukin-1β production in response to canonical and non-canonical inflammasome activation. Conclusions: Macrophage ontogeny is associated with distinct cellular programs and immune response. Our findings contribute to the understanding of the regulation and programming of macrophage functions.
Macrophages are cells of immune system and distributed throughout the body. They provide the first line of defense against microbial pathogen infections. Using bone marrow macrophages (BMMs) which derived from mice of strain BALB/c and strain C57BL/6, this study aimed to identify the changes in proteome of the macrophages due to IFN gamma stimulation and S. aureus infection. Two quantitative proteomic techniques, two-dimensional difference gel electrophoresis (2D-DIGE) and liquid chromatography-tandem mass spectrometry (LC-MS/MS) were applied in this study. The analysis results indicated that many proteins which play important roles in immunological functions of macrophages were changed due to IFN gamma stimulation and S. aureus infection. This study also identified the differences in proteome of macrophages derived from mice of strain BALB/c in comparing to macrophages of strain C57BL/6.
This thesis contains results from transcriptome studies on different aspects of host-pathogen interactions. First, liver gene expression profiles from a murine chronic stress model served to elucidate aspects of the influence of stress on metabolism and immune response state. Chronic stress in female BALB/c mice was shown to lead to a hypermetabolic syndrome including induction of gluconeogenesis, hypercholesteremia, and loss of essential amino acids, to the induction of the acute phase response, but also of immune suppressive pathways and to the repression of hepatic antigen presentation. Increased leukocyte trafficking, increased oxidative stress together with counter-regulatory gene expression changes, and an induction of apoptosis were detected. The influence of intra-venous infection on the host kidney gene expression was analyzed in another murine model using the wild type strain Staphylococcus aureus RN1HG and its isogenic sigB mutant. Gene expression profiling indicated a highly reproducible host kidney response to infection. The comparison of infected with non-infected samples revealed a strong inflammatory reaction of kidney tissue, e. g. Toll-like receptor signaling, complement system, antigen presentation, interferon and IL-6 signaling. However, the results of this study did not provide any hints for differences in the pathomechanism of the S. aureus strains RN1HG and ΔsigB, since the host response did not differ between infections with the two strains analyzed. Effects of SigB might be transient, only apparent at earlier time points, or might also be compensated for in the in vivo infection by the interlaced pattern of other regulators. SigB might possess only to a lesser extent characteristics attributed to virulence factors and might act in vivo more like a virulence modulator and fine tune bacterial reactions. In addition to the analysis of tissue samples, different in vitro models were furthermore studied. The third part of this thesis focuses on bone-marrow derived macrophages (BMM) of the two mouse strains BALB/c and C57BL/6, which are described in literature to exhibit genetically determined differences in their reaction to infection. Expression profiling was performed on control and IFN-γ treated samples from a serum-free cultivation system and revealed mainly induction of gene expression after treatment of BMM with IFN-γ. Gene expression changes confirmed known IFN-γ effects like induction of immunoproteasome, antigen presentation, interferon signaling related genes, GTPase/GBPs, and inducible NO synthase. IFN-γ dependent gene expression changes were highly similar in BALB/c and C57BL/6 BMM. Considering gene expression differences between BMM of both strains, a similar expression trend was visible on the level of untreated controls as well as after IFN-γ treatment. Differentially expressed genes between BMM of both strains included immune-relevant genes as well as genes linked to cell death, but the coverage of functional groups was limited. The bronchial epithelial cell line S9 was used as an in vitro model system for the infection with S. aureus RN1HG. The fourth chapter in this thesis includes S9 cell gene expression signatures 2.5 h and 6.5 h after start of infection. At the early time point, only 40 genes were differentially expressed, which nevertheless indicated a beginning pro-inflammatory response, e. g. induction of cytokines (IL-6, IFN-β, LIF) or prostaglandin-endoperoxide synthase 2 (PTGS2), but also counter-regulatory processes, e. g. induction of CD274. The host cell response was dramatically aggravated at the later 6.5 h time point. Differential expression was detected for 1196 genes. These included induced cytokines, pattern recognition receptor signaling, antigen presentation, and genes involved in immune defense (e. g. GBPs, MX, APOL). Negative effects on growth and proliferation were even more enhanced in comparison to the early time point, and signs for apoptotic processes were revealed. Finally, the last chapter addresses amongst others the pathogen’s expression profile in the S9 cell in vitro infection model at the two time points 2.5 h and 6.5 h after start of infection by tiling array gene expression analysis. The pathogen expression profiling revealed the activity of the SaeRS two-component system in internalized staphylococci. Partly dependent on SaeRS, the induction of adhesins (e. g. fnbAB, clfAB), toxins (hlgBC, lukDE, hla), and immune evasion genes (e. g. chp, eap) was observed. Furthermore, expression changes of metabolic genes were recorded (gene induction of amino acid biosynthesis, TCA cycle, gluconeogenesis; gene repression of glycolysis, purine biosynthesis, tRNA synthetases). Expression analysis recorded a distinct bacterial expression program, which supported literature results of a specific, bacterial strain and host cell line dependent transcriptional adaptation of the pathogen.
In summary, the transcriptome data demonstrated that acute RAP for 7h induces significant changes in the expression of several left atrial genes, including those reflecting ANG II-mediated oxidative stress, tissue remodeling, and energy depletion. Furthermore, the results from the dronedarone study demonstrated that this drug is capable of attenuating most of RAP-induced changes in oxidative stress-related gene expression. Accordingly, the haemodynamic parameters also showed that dronedarone reduced RAP-induced microvascular flow abnormalities. This view is supported by the observation that in the used porcine model of acute AF, dronedarone decreased RAP-dependent PKC phosphorylation, NADPH isoform expression, F2-isoprostane release and IκBα phosphorylation. Additionally, the results of the irbesartan study indicate that ET-1 contributes to AF-dependent atrial fibrosis by synergistic activity with ANG-II to stimulate SGK1 expression and enhance phosphorylation of the SGK1 protein which, in turn, induces CTGF. The latter has been consistently associated with tissue fibrosis. In support of this view, in vitro analyses using HL-1 cells verified CTGF induction after short episodes of RAP and additionally in response to exogenous addition of ET-1. Accordingly, irbesartan was shown to attenuate most of the RAP-dependent changes in atrial or ventricular gene expression.
Fibroblasts contribute to approximately 20% of the non-cardiomyocytic cells in the heart. They play important roles in the myocardial adaption to stretch, inflammation, and other pathophysiological conditions. Fibroblasts are a major source of extracellular matrix (ECM) proteins whose production is regulated by cytokines, such as TNF-α or TGF-β. The resulting myocardial fibrosis is a hallmark of pathological remodeling in dilated cardiomyopathy (DCM). Therefore, in the present study, the secretome and corresponding transcriptome of human cardiac fibroblasts from patients with DCM was investigated under normal conditions and after TNF-α or TGF-β stimulation. Secreted proteins were quantified via mass spectrometry and expression of genes coding for secreted proteins was analyzed via Affymetrix Transcriptome Profiling. Thus, we provide comprehensive proteome and transcriptome data on the human cardiac fibroblast’s secretome. In the secretome of quiescent fibroblasts, 58% of the protein amount belonged to the ECM fraction. Interestingly, cytokines were responsible for 5% of the total protein amount in the secretome and up to 10% in the corresponding transcriptome. Furthermore, cytokine gene expression and secretion were upregulated upon TNF-α stimulation, while collagen secretion levels were elevated after TGF-β treatment. These results suggest that myocardial fibroblasts contribute to pro-fibrotic and to inflammatory processes in response to extracellular stimuli.
Teil 1: Pathogeninaktivierung: Es wurde ein neues Verfahren zur Pathogeninaktivierung mittels Proteomanalysen untersucht. Bei diesem wurden Proben von Kaninchenthrombozyten mit Riboflavin bzw. Psoralen inkubiert und mit UV-A Licht bestrahlt. Dadurch werden die in Pathogenen enthaltenen Nukleinsäuren unbrauchbar gemacht, wohingegen gezeigt werden konnte, dass die Plättchen kaum in ihrem Proteom und damit vermutlich in ihrer Funktionalität beeinflusst wurden. Teil 2: Thrombozytenalterung: Durch Apherese wurde an drei auf einander folgenden Tagen die in einem humanen Spender zirkulierenden Plättchen auf 80000/µl depletiert und anschließend Plättchen aus dem Vollblut mittels differentieller Zentrifugation gewonnen. Während der einsetzenden Nachbildung von Thrombozyten wurde das Proteom der Zellen mit den Ausgangswerten verglichen und so versucht, Alterungsmarker im Thrombozytenproteom zu finden.
Zusammenfassung Das Ubiquitin-Proteasom-System (UPS) ist das wichtigste nicht-lysosomale proteolytische System für den Abbau intrazellulärer Proteine. Die Inhibition des UPS kann dosisabhängig den apoptotischen Zelltod oder die Induktion einer protektiven Stressantwort auslösen. In der therapeutischen Anwendung der Proteasominhibition sind neben der Wirksamkeit auch exakte Kenntnisse der Wirkungsweise essentiell, um die primären Effekte durch die Proteasominhibition besser zu erfassen und die initialen Effekte der Vermittlung dieser zellulären Reaktion besser zu verstehen. In dieser Arbeit wurden Methoden der Proteom- und Transkriptomebene kombiniert, um komplexe zelluläre Veränderungen von Endothelzellen nach Proteasomhemmung zu charakterisieren. Weiterhin wurde mittels Immunpräzipitation Ubiquitin-bindender Proteine untersucht, welche Substrate des Proteasoms nach Proteasomhemmung in Endothelzellen stabilisiert werden. Primäre humane Endothelzellen (Huvec) wurden als Modell gewählt und mit niedrigen bzw. hohen Dosierungen des Proteasominhibitors MG132 behandelt. Das Expressionsprofil wurde in einer Zeitkinetik innerhalb der ersten 6h mittels Affymetrix Chipanalysen bestimmt. Die differentielle Proteinexpression nach zwei Stunden Proteasomhemmung wurde im Gesamtzelllysat durch 2D Gelelektrophorese und anschließende Silberfärbung visualisiert. Dabei konnten mehr als 20 regulierte Proteine identifiziert werden, welche zuvor nicht direkt im Zusammenhang mit der Vermittlung einer protektiven Stressantwort nach niedrig dosierter Proteasomhemmung bekannt waren. Durch Korrelation mit den parallel durchgeführten Expressionsarrays konnte die Regulation dieser Proteine als unabhängig von der Transkription erfasst werden. Die funktionelle Annotation der Daten zeigte dabei eine Anreicherung von Proteinen der zellulären Stressantwort, der intrazellulären Signaltransduktion und des oxidativen Stresses. Diese waren differentiell reguliert nach niedrig bzw. hoch dosierter Proteasominhibition. Während die niedrig dosierte Proteasominhibition ein protektives Genmuster zeigte, induzierten hohe Dosen den apoptotischen Zelltod. Auch konnte, in Abhängigkeit vom Grad der Proteasominhibition, ein deutlicher Anstieg der freien Radikale innerhalb der Zellen nachgewiesen werden, was auf die Vermittlung der Apoptose durch freie Radikale hinweist. Mit DJ-1, Peroxiredoxin-1 und -6 wurden mehrere Sensorproteine für oxidativen Stress identifiziert. Um, neben der Proteom- und Transkriptomanalyse, auch gezielt Substrate der Proteasominhibition zu identifizieren und als mögliche Mediatoren der protektiven Stressantwort zu identifizieren, wurden Gesamtzelllysate mittels Ubiquitin-Immunpräzipitation getrennt und Ubiquitin-bindende Proteine per Massenspektrometrie identifiziert. Dabei konnte ein Set von 22 Proteinen identifiziert werden, welche spezifisch nach 2h an der Ubiquitin-spezifischen Matrix gebunden wurden. In diesem Set finden sich vor allem RNA bindende Proteine, Bestandteile des UPS und ribosomale Proteine. Um gezielt transkriptionelle Mediatoren der protektiven Stressantwort nach partieller Proteasominhibition zu identifizieren, wurde eine Subproteom-Analyse mit nukleären Extrakten von Huvec durchgeführt. Nach Visualisierung mittels DIGE-Labeling und quantitativer Auswertung konnten 361 regulierte Spots nach 2 stündiger Proteasominhibition erfasst werden. Von diesen Spots konnten 319 per MALDI-MS identifiziert werden und 152 verschiedenen Proteinen zugeordnet werden. Die funktionelle Auswertung ergab eine deutliche Überrepräsentation von RNA-bindenden und Splicing-relevanten Proteinen. Auch konnte für HnRNP A1, einem RNA-bindenden Protein, eine funktionelle Methylierung sowie eine Veränderung der subzellulären Lokalisierung nachgewiesen werden. Diese Ergebnisse deuten auf die Regulation des zellulären Splicings hin. In parallel dazu angefertigten Exon-sensitiven Affymetrix Arrays wurden über 600 Gene mit differentiell regulierten Exons identifiziert, welche vor allem Gene mit Rezeptor- und Transportproteinen kodieren. Auch eine erhöhte Anzahl von Genen mit Methyltransferase-/Kinaseaktivität wurde identifiziert. Insbesondere die Methyltransferasen, welche auch bei der posttranslationalen Modifikation von HnRNP A1 eine Rolle spielen, zeigten dabei eine signifikante Regulation unter niedrig dosierter Proteasominhibition. Zusammengefasst tragen die in dieser Arbeit vorgestellten Ergebnisse dazu bei, einen detaillierten Überblick über die initialen Prozesse niedrig dosierter Proteasominhibition in Endothelzellen zu geben. Die Daten deuten dabei auf eine schnelle Adaptation der Zellen nach partieller Proteasomhemmung mittels Aktivierung einer anti-oxidativen Stressantwort sowie durch Regulation von Splicingvorgängen hin, die letztendlich in einem veränderten Expressionsprofil der Endothelzellen münden. Mit diesem systematischen Ansatz und der Kombination von Proteom- und Transkriptomanalyse konnten dabei einzelne Targets für die Mediation einer protektiven zellulären Stressantwort nach partieller Proteasomhemmung identifiziert werden.
Dilated cardiomyopathy (DCM) is a myocardial disorder characterised by ventricular dilation with reduced left ventricular ejection fraction (LVEF). Immunoadsorption (IA) followed by immunoglobulin (IgG) substitution (IA/IgG) has been shown to be a promising therapeutic intervention to recover myocardial functions in DCM patients. The beneficial effects of IA/IgG therapy are associated with increased LVEF, decreased left ventricular inner diameter at diastole (LVIDd) and reduced myocardial inflammation. Despite knowing the cardiac benefits of IA/IgG, the precise molecular mechanism induced by therapy is still elusive. Additionally, only ≈60 % DCM patients treated with IA/IgG demonstrated improved heart function. Moreover, the reasons for this differential outcome among DCM patients after treatment have not been clearly understood. In this study, efforts were made to uncover the therapy induced proteomic changes in the heart of responders (relative change in LVEF ≤ 20%, LVEF < 5% absolute value) and non-responders using a global proteomic approach. Apart from it, proteomic profiling of endomyocardial biopsies and plasma was performed to find protein biomarker candidates which might be useful to distinguish responder and non-responder DCM patients before immunoadsorption therapy and support a selective and individualized treatment. To reveal therapy induced myocardial proteomic changes, endomyocardial biopsies of DCM patients before and after therapy were compared. LVEF increased (32 ± 8 to 45±7, p<0.002) and LVIDd decreased (66 ± 6 to 60±6, p<0.040) after therapy in responders, whereas non-responders did not show any significant changes in these clinical parameters. To address the changes in the myocardial proteome induced by therapy, a label-free proteomic approach was applied. The most prominent proteomic differences between both subgroups were observed in cytoskeletal, fibrosis, and extracellular matrix proteins. Therapy linked benefit in responders seems to be highly associated with the lower abundance of fibrotic and extracellular matrix proteins which seems to reflect a lower activity of transforming growth factor-β signaling. To elucidate proteomic differences between responders and non-responders at baseline, endomyocardial biopsies and plasma proteome profiling were performed. Responder and non-responder DCM patients did not show any significant differences in the clinical parameters (LVEF, LVIDd, age, inflammation, etc.) before IA/IgG therapy except for disease duration that was in tendency higher among non-responders. Proteomics profiling of endomyocardial biopsies revealed 54 differentially abundant proteins between responders and non-responders. Among those proteins, Protein S100-A8 and kininogen-1 was found higher whereas perilipin-4 was found lower abundant in responders. Plasma profiling of these subgroups revealed five proteins (S100-A8, S100-A9, C-Reactive protein, lipopolysaccharide-binding protein, and cysteine-rich secretory protein) displaying strong discriminative power between responders and non-responders. Higher abundance of Protein S100-A8 was observed in myocardium as well as in plasma among responders. Protein S100-A8 might be a potential candidate to distinguish responders and non-responders at baseline, and its potential utility at clinical levels must be evaluated. The last objective of the thesis was to establish a workflow for the relative quantitation of phosphopeptides for samples generally obtained in small amounts like myocardial biopsies. To address this question, optimization was performed with HL-1 cardiomyocytes using a PolyMAC phosphopeptide enrichment kit and the effect of TGF-β1 on the phosphoproteome was evaluated as a proof-of-principle study. Using only 200µg protein of each sample up to 2000 phosphopeptides with an efficiency of >90 percent could be covered. In total, upon TGF-β1 incubation alterations of 214, 92, and 53 phosphopeptides were observed after 1, 6 and 24 hours, respectively. Differentially altered phosphopeptides belonged to many signaling pathways including the ubiquitin-proteasome pathway, cytoskeletal regulation by Rho GTPase, calcium signaling, and TGF-β signaling. Thus, in this study a workflow for relative quantitation of phosphopeptides was established that may be later applied to precious biopsy samples. Along with this, TGF- β1 induced phosphoproteome was analysed in HL-1 cardiomyocytes.
Die Transfusionsassoziierte Akute Lungeninsuffizienz (TRALI) ist die häufigste tödliche Nebenwirkung der Transfusion von Blutprodukten und wird oft durch mittransfundierte leukozytenreaktive Antikörper (AK) induziert. AK gegen das Humane Neutrophilenantigen (HNA)-3a verursachen häufig schwere Fälle der TRALI. HNA-3a ist auf dem Großteil der Blutzelltypen exprimiert und entsteht durch einen Einzelnukleotidpolymorphismus im Gen des „choline transporter-like protein 2“ (CTL2), welcher zur Substitution der Aminosäureposition 154 in der Sequenz des Proteins führt. Klinische Beobachtungen und zahlreiche Studien legen nahe, dass TRALI-induzierende AK die Akkumulation und Aktivierung von Granulozyten im Lungenkapillarbett verursachen. Durch den Zusammenbruch der Kapillarbarriere kommt es in der Folge zu einem Lungenödem. Die Entwicklung eines Hochdurchsatzverfahrens zur Detektion von HNA-3a-AK in Blutprodukten und die Identifizierung therapierelevanter Schaltstellen, im Pathomechanismus der HNA-3a-AK-induzierten TRALI, waren daher Hauptschwerpunkte dieser Studie. In diesem Zusammenhang wurde ein Nachweissystem für HNA-3a-AK auf der Grundlage von CTL2-Fragmenten etabliert. Ein Screening zahlreicher Anti-HNA-3a-Plasmen ergab, dass mit CTL2-Peptiden in Festphasentests jedoch nur etwa 50% aller HNA-3a-AK nachgewiesen werden können. Weitere Untersuchungen ergaben, dass die Detektion aller HNA-3a-AK nur mit zellbasierten Methoden möglich ist, bei denen CTL2 in seiner natürlichen Konformation vorliegt. Diese Studie leistet damit einen wichtigen Beitrag zur Charakterisierung des konformationssensitiven Epitops der HNA-3a-AK und identifiziert wichtige Grundvoraussetzungen für Methoden zum Nachweis dieser AK. Ein weiterer Schwerpunkt dieser Arbeit war die Untersuchung der Interaktion zwischen HNA-3a-AK und Granulozyten. Dieser experimentelle Ansatz gründet auf histopathologischen Lungenuntersuchungen verstorbener TRALI-Patienten, die eine massive Akkumulation und Aggregation von Granulozyten in den Kapillaren aufzeigen. Aus diesem Grund erfolgte die Untersuchung dieser Interaktion zunächst hinsichtlich verschiedener Parameter, die zu einer gesteigerten Sequestrierung von Granulozyten in der Lunge führen können. Hierzu gehören die Granulozytenaggregation (GA), die Versteifung von Zellen und die Zelladhäsion. Die Modifikation des Standard-Granulozytenaggregationstests ergab, dass die HNA-2- und HNA-3a-AK-induzierte GA aktive Prozesse sind, welche unabhängig von Plasmafaktoren stattfinden, jedoch von der Aktivität einer bislang noch nicht identifizierten Serinprotease abhängig sind. Hierbei wurden potente Aggregationsinhibitoren identifiziert welche auch als potenzielle Therapeutika zur Behandlung von TRALI in Frage kommen. Mit Hilfe desselben Testsystems konnte ermittelt werden, dass voraktivierte Granulozyten eine erhöhte Aggregationsneigung aufweisen. Im Zusammenhang mit dem Schwellenwertmodell der TRALI liefert dieses Ergebnis eine mögliche Erklärung, warum Patienten mit schweren Vorerkrankungen häufiger an TRALI erkranken. Neben der GA wurden in dieser Studie zwei weitere Eigenschaften identifiziert, die eine Akkumulation der Zellen in den engen Lungenkapillaren erklären: deren Elastizität und Adhäsivität. Mithilfe der Rasterkraftmikroskopie wurde nachgewiesen, dass HNA-3a-AK eine Versteifung von Granulozyten induzieren. Ebenso wurde gezeigt, dass HNA-3a-AK das Integrin Mac-1 (CD11b/CD18) auf der Granulozytenoberfläche aktivieren, was zu einer verstärkten Adhäsion der Zellen an Fibrinogen führt. Steifere und adhäsivere Granulozyten akkumulieren möglicherweise vermehrt in den Lungenkapillaren. Eine weitere wichtige Fragestellung dieser Studie war, ob HNA-3a-AK eine direkte Aktivierung von Granulozyten auslösen. Die Untersuchungen ergaben, dass die Aktivierung von CD11b, weder mit der Erhöhung der CD11b-Expression, bzw. mit der proteolytischen Abspaltung von L-Selektin, noch mit einer Sauerstoffradikalproduktion einhergeht. Dieses ungewöhnliche Muster an Veränderungen deutet nicht auf eine Aktivierung zytotoxischer Antworten hin. Seit kurzem ist bekannt, dass HNA-3a-AK Kapillarendothelzellen auch auf direktem Wege aktivieren und dass selbst in Granulozyten-depletierten Mäusen schwache TRALI-Symptome auftreten. Demzufolge ergibt sich ein neues Modell der HNA-3a-AK-induzierten TRALI: Nach Transfusion von HNA-3a-AK bleiben aggregierte, steifere und adhäsivere Granulozyten in den engen Lungenkapillaren stecken und interagieren dort mit dem aktivierten Gefäßendothel. Durch diese Interaktion kommt es vermutlich zur Aktivierung der Granulozyten und zu einer starken Inflammationsreaktion, welche eine weitere Zerstörung der Lungenkapillaren und schließlich ein schweres Lungenödem zur Folge hat. Die besondere Schwere der HNA-3a-AK-induzierter TRALI entsteht also vermutlich nicht aufgrund einer direkten und starken Granulozytenaktivierung, sondern vielmehr durch die gleichzeitige Beeinflussung verschiedener epitoptragender Zelltypen.
Background and Aims
Gallbladder cancer (GBC) is a neglected disease with substantial geographical variability: Chile shows the highest incidence worldwide, while GBC is relatively rare in Europe. Here, we investigate the causal effects of risk factors considered in current GBC prevention programs as well as C‐reactive protein (CRP) level as a marker of chronic inflammation.
Approach and Results
We applied two‐sample Mendelian randomization (MR) using publicly available data and our own data from a retrospective Chilean and a prospective European study. Causality was assessed by inverse variance weighted (IVW), MR‐Egger regression, and weighted median estimates complemented with sensitivity analyses on potential heterogeneity and pleiotropy, two‐step MR, and mediation analysis. We found evidence for a causal effect of gallstone disease on GBC risk in Chileans (P = 9 × 10−5) and Europeans (P = 9 × 10−5). A genetically elevated body mass index (BMI) increased GBC risk in Chileans (P = 0.03), while higher CRP concentrations increased GBC risk in Europeans (P = 4.1 × 10−6). European results suggest causal effects of BMI on gallstone disease (P = 0.008); public Chilean data were not, however, available to enable assessment of the mediation effects among causal GBC risk factors.
Conclusions
Two risk factors considered in the current Chilean program for GBC prevention are causally linked to GBC risk: gallstones and BMI. For Europeans, BMI showed a causal effect on gallstone risk, which was itself causally linked to GBC risk.
Although the nose, as a gateway for organism–environment interactions, may have a key role in asthmatic exacerbation, the rhinobiome of exacerbated children with asthma was widely neglected to date. The aim of this study is to understand the microbiome, the microbial immunology, and the proteome of exacerbated children and adolescents with wheeze and asthma. Considering that a certain proportion of wheezers may show a progression to asthma, the comparison of both groups provides important information regarding clinical and phenotype stratification. Thus, deep nasopharyngeal swab specimens, nasal epithelial spheroid (NAEsp) cultures, and blood samples of acute exacerbated wheezers (WH), asthmatics (AB), and healthy controls (HC) were used for culture (n = 146), 16 S-rRNA gene amplicon sequencing (n = 64), and proteomic and cytokine analyses. Interestingly, Proteobacteria were over-represented in WH, whereas Firmicutes and Bacteroidetes were associated with AB. In contrast, Actinobacteria commonly colonized HCs. Moreover, Staphylococcaceae, Enterobacteriaceae, Burkholderiaceae, Xanthobacteraceae, and Sphingomonadaceae were significantly more abundant in AB compared to WH and HC. The α-diversity analyses demonstrated an increase of bacterial abundance levels in atopic AB and a decrease in WH samples. Microbiome profiles of atopic WH differed significantly from atopic AB, whereby atopic samples of WH were more homogeneous than those of non-atopic subjects. The NAEsp bacterial exposure experiments provided a disrupted epithelial cell integrity, a cytokine release, and cohort-specific proteomic differences especially for Moraxella catarrhalis cultures. This comprehensive dataset contributes to a deeper insight into the poorly understood plasticity of the nasal microbiota, and, in particular, may enforce our understanding in the pathogenesis of asthma exacerbation in childhood.
Myokardiale Erkrankungen gehören zu den häufigsten Todesursachen. Das Verständnis der molekularen, patho-physiologischen Ereignisse ist somit entscheidend für die Suche nach geeigneten Therapien. Um einen Einblick in zelluläre Ereignisse der kardialen Erkrankungen zu erhalten, sollten in der hier vorgelegten Arbeit Genexpressionsanalysen unter Verwendung von DNA-Mikroarrays durchgeführt werden. Den Schwerpunkt dieser Arbeit bildete die Charakterisierung der Immunadsorptionstherapie (IA/IgG-Therapie), die eine Therapieoption der dilatativen Kardiomyopathie (DCM) darstellt. Anhand von Genexpressionsanalysen immunadsorbierter Patienten sollte der Therapieeffekt analysiert werden. Dafür wurde zunächst die Etablierung eines Protokolls zur Isolation von Protein und RNA aus humanen endomyokardialen Biopsien von DCM-Patienten nötig. Um die mit der Therapie verbundenen Genexpressionsänderungen einordnen zu können, sollte zunächst das Genexpressionsmuster von 47 DCM-Patienten mit Patienten ohne Einschränkung der Pumpfunktion (Kontrollen) verglichen und mittels Real-time PCR validiert werden. Die Betrachtung dieser DCM-Patienten und Patienten, die eine normale Pumpfunktion aufwiesen, ergab 649 Gene mit krankheitsbedingt veränderter Expression. Zu diesen gehören neben bekannten Herzinsuffizienz-Markern (BNP, ANP, MYH6) Gene, die Proteine des Protein-Ubiquitinylierungssystem kodieren oder an der Ausprägung von Hypoxie und Fibrose (Connective tissue growth factor) beteiligt sind und auf eine Dysregulation des Proteinabbaus, erhöhten oxidativen Stress und Matrix-Remodeling hinweisen. Darüber hinaus ist aufgrund der geringeren Expression von Genen, die der oxidativen Phosphorylierung und Glykolyse zuzuordnen sind, von einer Energielimitation in DCM-Patienten auszugehen. Unter Berücksichtigung von verschiedenen klinischen Parametern bestand weiterhin die Aufgabe, den Einfluss dieser Parameter auf die Genexpression zu klären. Während wenig Korrelationen zu Body-Mass-Index (BMI), Alter und Krankheitszeitraum auftrat, wurde eine Häufung von Genen festgestellt, deren Expression zur LVEF und LVIDd korreliert. Gene, die Regulatoren mit myokardialer Funktion kodieren (ADRA1A, ADRB2, PLN, RYR2), zeigten gleichzeitig Korrelationen zur LVEF und dem LVIDd (p<0,05). Darüber hinaus sollte das Genexpressionsprofil von Patienten, die von der IA/IgG-Therapie profitieren (Responder) mit den Patienten ohne Therapieerfolg (Nonresponder) vor und 6 Monate nach der IA/IgG-Therapie verglichen werden. In der Subgruppe der Responder wurde für 171 Gene eine signifikant unterschiedliche Expression bestimmt, während die Zahl der durch die Therapie in ihrer Expressionshöhe betroffenen Gene in Nonrespondern mit 72 wesentlich geringer ausfiel. Gene, die sowohl in Respondern nach Therapie als auch krankheitsbedingt verändert waren, konnten kaum beobachtet werden, so dass andere Mechanismen für den Therapieeffekt verantwortlich sein müssen. Neben einer geringeren Expression des ACE2 wurde auch eine Abnahme Fibrose-assoziierter Gene wie CTGF, Fibronectin und Collagen 1A2 in Respondern nach IA/IgG-Therapie beobachtet. Zudem war eine signifikante LVIDd-Abnahme in Respondern zu verzeichnen, die in Nonrespondern nicht zu erkennen war. In Nonrespondern wurde nach IA/IgG-Therapie dagegen die verminderte Expression einiger Komplementfaktoren beobachtet. Zudem bestand die Aufgabe in der Suche nach Genexpressionsänderungen immunadsorbierter DCM-Patienten, die mit der Änderung klinischer Parameter korrelieren. Weiterhin sollte im Rahmen dieser Arbeit eine beschreibende Signatur definiert werden, die eine Vorhersage des Therapieerfolges für den individuellen DCM-Patienten vor Durchführung der IA/IgG-Therapie ermöglicht. Unter Verwendung des Resamplings (Crossvalidierung) wurde mit Hilfe einer Support Vector Machine eine Signatur von 25 Genen definiert, die eine Klassifizierung der Subgruppen mit einer Fehlerrate von 3,7% erlaubt. Die in Abhängigkeit verschiedener, myokardialer Parameter gezeigten Genexpressionsunterschiede in DCM-Patienten spiegeln die Dynamik der Erkrankung wider. Der Einfluss der IA/IgG-Therapie auf die Genexpression von Patienten, die an der DCM erkrankt sind, betrifft eine Vielzahl von Genen verschiedener Kategorien. Korrelationsanalysen zeigen, dass ein Zusammenhang zwischen Genexpressionsänderung und den Änderungen der Parameter LVEF, LVIDd und Inflammation bestehen. Mit der Definition von Patienten, die von der IA/IgG-Therapie profitieren, wurden auch Unterschiede bezüglich klinischer Parameter (LVIDd, Zeitraum der Erkrankung) deutlich, die zum Verständnis der hier dargestellten Genexpressionsunterschiede beitragen. Die generierten Daten bieten neben dem besseren Verständnis der im Myokard ablaufenden Prozesse eine Reihe von Ansatzpunkten für weitere Untersuchungen, wie zum Beispiel zur Rolle des IGF-1-Signalweges oder des Protein-Ubiquitinylierungssystems bei der Ausprägung der DCM, die auch zu neuen Therapieansätzen beitragen können.